50 results on '"Lisa Tjosvold"'
Search Results
2. Northern Alberta Health Libraries Association
- Author
-
Lisa Tjosvold
- Subjects
Bibliography. Library science. Information resources - Published
- 2014
- Full Text
- View/download PDF
3. Creating Provincial and Territorial Search Filters to Retrieve Studies Related to Canadian Indigenous Peoples from Ovid MEDLINE
- Author
-
Sandy Campbell, Marlene Dorgan, and Lisa Tjosvold
- Subjects
Bibliography. Library science. Information resources - Abstract
Introduction: Performing systematic review searches related to Canadian Indigenous peoples (First Nations, Inuit, and Métis), particularly in areas of public health, is difficult because Medical Subject Headings (MeSH) terms for both Indigenous peoples and geography do not retrieve all relevant articles in Ovid MEDLINE. Text–word searching for Canadian Indigenous peoples presents challenges in the varieties of names, spellings, and languages. A series of Canadian Indigenous peoples filters were designed to retrieve larger numbers of relevant articles. Objectives: The objectives of this work were (i) to create first-generation search filters that retrieve studies from the Ovid MEDLINE database related to Canadian Indigenous peoples, (ii) to determine whether or not the filters retrieve more records than do searches using the MeSH headings alone, and (iii) to determine how many of the additional records are relevant. Methods: Key terms describing both Canadian Indigenous peoples and Canadian geography were identified using government, historical, and ethnographic publications. Name lists included current and historical names in multiple languages, as well as local and settlement names, and names of linguistic groups. Filters, employing both text–word and MeSH terms were created for each province and territory, excluding Prince Edward Island. Search results were reviewed for false recalls related to terms with multiple meanings and groups of people whose lands straddle provincial and territorial borders. Revised searches were refined with additional terminology that implies the presence of Indigenous peoples. Duplicate records were removed from both the MeSH searches and the filter searches. Results from the MeSH searches were then removed from the results of the filter searches. The remaining results were analyzed for relevance. Results: Twelve Ovid MEDLINE filters were created and the challenges involved in creating them were documented. The filters increased recall by 58 articles, 464% over MeSH searches alone. Of the additional articles retrieved, 28 (100%) met the criteria for relevance. Discussion: The lists of challenges identified in the filter creation will assist other searchers in developing similar filters. The filters allow searchers to retrieve substantially more articles than is currently possible with the MeSH terms alone.
- Published
- 2014
- Full Text
- View/download PDF
4. Treatment of hepatitis C in children: a systematic review.
- Author
-
Jia Hu, Karen Doucette, Lisa Hartling, Lisa Tjosvold, and Joan Robinson
- Subjects
Medicine ,Science - Abstract
BackgroundCurrent guidelines recommend children be treated for hepatitis C virus (HCV) using the same principles applied in adults. There are however few published studies which assess the efficacy and safety of HCV therapy in children.Methodology/principal findingsA systematic review of the literature was completed for studies of any design that evaluated HCV therapy in children. The primary outcome was sustained virologic response (SVR), with sub-group analysis of response rates by genotype. There were 4 randomized controlled trials (RCTs) and 31 non-randomized studies, all involving interferon, pegylated interferon (PEG-IFN), or combinations of these drugs with ribavirin. The SVR rate could not be directly compared as the populations and interventions differed across studies. Genotype was not reported or differed substantially from study to study. The overall SVR rate for PEG-IFN and ribavirin ranged from 30 to 100% which is comparable to the rate in adults. Similar to adults, the SVR rates were significantly higher in children with genotype 2 or 3 compared to genotype 1. Adverse effects were primarily flu-like symptoms and neutropenia. There were insufficient data to assess the applicability of the week 12 stop rule (stopping therapy at week 12 if there is less than a 2 log drop in HCV RNA) or the efficacy of shortening therapy to 24 weeks in children with genotype 2 and 3.Conclusions/significanceCurrent guidelines for the treatment of HCV in children are based on limited data. Further research is needed to define the optimal therapy for HCV in children.
- Published
- 2010
- Full Text
- View/download PDF
5. Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006.
- Author
-
Denise Thomson, Lisa Hartling, Eyal Cohen, Ben Vandermeer, Lisa Tjosvold, and Terry P Klassen
- Subjects
Medicine ,Science - Abstract
BACKGROUND: The objective of this study was to describe randomized controlled trials (RCTs) and controlled clinical trials (CCTs) in child health published between 1948 and 2006, in terms of quantity, methodological quality, and publication and trial characteristics. We used the Trials Register of the Cochrane Child Health Field for overall trends and a sample from this to explore trial characteristics in more detail. METHODOLOGY/PRINCIPAL FINDINGS: We extracted descriptive data on a random sample of 578 trials. Ninety-six percent of the trials were published in English; the percentage of child-only trials was 90.5%. The most frequent diagnostic categories were infectious diseases (13.2%), behavioural and psychiatric disorders (11.6%), neonatal critical care (11.4%), respiratory disorders (8.9%), non-critical neonatology (7.9%), and anaesthesia (6.5%). There were significantly fewer child-only studies (i.e., more mixed child and adult studies) over time (P = 0.0460). The proportion of RCTs to CCTs increased significantly over time (P
- Published
- 2010
- Full Text
- View/download PDF
6. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review.
- Author
-
Maria B Ospina, Jennifer Krebs Seida, Brenda Clark, Mohammad Karkhaneh, Lisa Hartling, Lisa Tjosvold, Ben Vandermeer, and Veronica Smith
- Subjects
Medicine ,Science - Abstract
BackgroundMuch controversy exists regarding the clinical efficacy of behavioural and developmental interventions for improving the core symptoms of autism spectrum disorders (ASD). We conducted a systematic review to summarize the evidence on the effectiveness of behavioural and developmental interventions for ASD.Methods and findingsComprehensive searches were conducted in 22 electronic databases through May 2007. Further information was obtained through hand searching journals, searching reference lists, databases of theses and dissertations, and contacting experts in the field. Experimental and observational analytic studies were included if they were written in English and reported the efficacy of any behavioural or developmental intervention for individuals with ASD. Two independent reviewers made the final study selection, extracted data, and reached consensus on study quality. Results were summarized descriptively and, where possible, meta-analyses of the study results were conducted. One-hundred-and-one studies at predominantly high risk of bias that reported inconsistent results across various interventions were included in the review. Meta-analyses of three controlled clinical trials showed that Lovaas treatment was superior to special education on measures of adaptive behaviour, communication and interaction, comprehensive language, daily living skills, expressive language, overall intellectual functioning and socialization. High-intensity Lovaas was superior to low-intensity Lovaas on measures of intellectual functioning in two retrospective cohort studies. Pooling the results of two randomized controlled trials favoured developmental approaches based on initiative interaction compared to contingency interaction in the amount of time spent in stereotyped behaviours and distal social behaviour, but the effect sizes were not clinically significant. No statistically significant differences were found for: Lovaas versus special education for non-verbal intellectual functioning; Lovaas versus Developmental Individual-difference relationship-based intervention for communication skills; computer assisted instruction versus no treatment for facial expression recognition; and TEACCH versus standard care for imitation skills and eye-hand integration.ConclusionsWhile this review suggests that Lovaas may improve some core symptoms of ASD compared to special education, these findings are based on pooling of a few, methodologically weak studies with few participants and relatively short-term follow-up. As no definitive behavioural or developmental intervention improves all symptoms for all individuals with ASD, it is recommended that clinical management be guided by individual needs and availability of resources.
- Published
- 2008
- Full Text
- View/download PDF
7. Quality of reporting of economic evaluations in rehabilitation research: a systematic review
- Author
-
Mike Paulden, Susan Armijo-Olivo, Julie Flemming, Lisa Tjosvold, and Dagmara Chojecki
- Subjects
Occupational therapy ,030506 rehabilitation ,medicine.medical_specialty ,Cost-Benefit Analysis ,media_common.quotation_subject ,medicine.medical_treatment ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,medicine ,Humans ,Mass Screening ,Quality (business) ,Prospective Studies ,media_common ,Rehabilitation ,Limiting ,Checklist ,Rehabilitation research ,Rehabilitation Research ,Economic evaluation ,InformationSystems_MISCELLANEOUS ,0305 other medical science ,Psychology ,030217 neurology & neurosurgery - Abstract
The quality of reporting of health economic evaluations for rehabilitation services has been questioned, limiting the ability to provide accurate recommendations for health decisions.To document current overall reporting quality of the published literature for economic evaluations of rehabilitation services using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS), and to identify factors that could influence the quality of reporting.Electronic literature searches were performed using MEDLINE and the NHS Economic Evaluations DatabaseProspective rehabilitation economic evaluation articles from 2013 to 2020 were selected.Data were extracted by one reviewer and independently verified by a second reviewer.Title and abstracts of 3,454 papers were reviewed. 204 papers were selected for a full text screening. From those, 129 potential papers were identified to be included in this study.Only two databases were used in data collection, and papers were selected from 2013 to 2020 only.Inconsistent reporting in health economic evaluations of rehabilitation services has continued, despite the availability of the CHEERS checklist. The methods of the analyzed studies were frequently under-reported, thereby creating challenges in determining whether the results reported were valid.IMPLICATIONS FOR REHABILITATIONVariable quality of reporting has been identified in rehabilitation research assessing cost-effectiveness.To grow as an area of expertise, the field of rehabilitation must produce research demonstrating its cost-effectiveness.Both rehabilitation clinicians and funders would benefit from full and transparent information to identify optimal solutions for effective and efficient care.
- Published
- 2020
8. Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials
- Author
-
Lisa Tjosvold, Danielle K. Nagy, Dean T. Eurich, John-Michael Gamble, and Jill Hall
- Subjects
Blood Glucose ,medicine.medical_specialty ,Active Comparator ,Sodium Chloride Symporter Inhibitors ,medicine.medical_treatment ,Placebo ,01 natural sciences ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,Humans ,Medicine ,030212 general & internal medicine ,0101 mathematics ,Diuretics ,Antihypertensive Agents ,Thiazide ,Randomized Controlled Trials as Topic ,Glycemic ,Review Paper ,business.industry ,010102 general mathematics ,Fasting ,medicine.disease ,Meta-analysis ,Hypertension ,Diuretic ,business ,medicine.drug - Abstract
BACKGROUND: Prior meta-analyses measuring thiazide-induced glycemic change have demonstrated an increased risk of incident diabetes; however, this measure’s definition has changed over time. AIM: To determine the magnitude of change in fasting plasma glucose (FPG) for thiazide diuretics. DATA SOURCES: A research librarian designed and conducted searches in Medline®, EMBASE, and EBM Reviews-Cochrane Central Register of Controlled Trials (inception through July 2018) and International Pharmaceutical Abstracts (inception to December 2014). STUDY SELECTION: Randomized, controlled trials comparing a thiazide or thiazide-like diuretic to any comparator reporting FPG were identified. Trials enrolling
- Published
- 2020
9. A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness and cost-effectiveness of private providers of elective surgical services compared with public providers
- Author
-
Ilke Akpinar, Erin Kirwin, Lisa Tjosvold, Dagmara Chojecki, and Jeff Round
- Subjects
Cost effectiveness ,Clinical effectiveness ,medicine ,Business ,Medical emergency ,medicine.disease - Abstract
Many publicly funded health systems use a mix of privately and publicly operated providers of care to deliver elective surgical services. We review the role of private elective surgical provision within publicly funded health systems in high-income countries. The outcomes evaluated include accessibility, acceptability, safety, clinical effectiveness, efficiency, and cost/cost-effectiveness. Twenty-seven articles met the review inclusion criteria. We found mixed results across each of our reported outcomes. Wait times were shorter for patients treated in private facilities in most studies, and inequalities by age and socioeconomic deprivation were found to increase with private provision in some studies. Acceptability results were mixed, with most studies finding no differences between public and private provision and others finding higher satisfaction at public facilities. The results for safety outcomes were divided, but most studies that found improved safety outcomes in private facilities, noting that private patients had a lower preoperative risk of complications. Clinical effectiveness was similar in most studies, with differences in outcomes mainly attributed to patient selection or prosthesis choice. Very few studies reported cost and cost-effectiveness outcomes, and just two included studies concluded that private facilities are economically viable.
- Published
- 2021
10. Systematic review of community pharmacy–based and pharmacist-led foot care interventions for adults with type 2 diabetes
- Author
-
Lisa Tjosvold, Jeffrey A. Johnson, Allison Soprovich, Vishal Sharma, and Dean T. Eurich
- Subjects
medicine.medical_specialty ,business.industry ,Psychological intervention ,Pharmacist ,MEDLINE ,Pharmaceutical Science ,030209 endocrinology & metabolism ,Pharmacy ,Type 2 diabetes ,Disease ,medicine.disease ,Diabetic foot ,03 medical and health sciences ,0302 clinical medicine ,Research and Clinical ,Community pharmacy ,Family medicine ,medicine ,030212 general & internal medicine ,business ,Foot care - Abstract
Background: To prevent diabetic foot disease, proper foot care is essential for early detection and treatment. Pharmacists are well suited to provide accessible foot care to adults with type 2 diabetes. Limited research has examined this role. Methods: We conducted a systematic review of community pharmacy–based and pharmacist-led foot care interventions for adults with type 2 diabetes compared to usual care. Data sources included MEDLINE, EMBASE, the Cochrane Library, CINAHL, Academic Search Complete and Health Source: Nursing/Academic Edition and Google Scholar, plus Google and hand-searching. Original research studies reported in English, focused on community pharmacy–based or pharmacist-led foot care interventions were eligible for review. Participants were adults with type 2 diabetes. Studies were summarized narratively; pooled data were not possible. Results: Seven studies were included in this review, 3 focusing on improving foot self-care behaviours and 4 on promoting foot examinations by the health care provider. Only 2 studies were randomized and were assessed as high quality. Six out of 7 studies reported significantly positive findings related to foot care practices. Discussion: An opportunity to influence foot care exists at each clinical encounter. Pharmacists are accessible health care practitioners and appropriate to provide a range of diabetes foot care interventions. Conclusions: Seven studies examined community pharmacy–based and pharmacist-led foot care interventions for people with type 2 diabetes. Community pharmacies and pharmacists are capable of providing a variety of foot care interventions to patients with diabetes, helping detect problems early and leading to prompt intervention.
- Published
- 2019
11. Methodological Issues in Rehabilitation Research: A Scoping Review
- Author
-
Michele Patrini, Stefano Negrini, Chiara Arienti, Lisa Tjosvold, Stefano G. Lazzarini, Susan Armijo-Olivo, and Silvia Minozzi
- Subjects
Protocol (science) ,Rehabilitation ,Evidence-based practice ,Blinding ,medicine.medical_treatment ,MEDLINE ,Physical Therapy, Sports Therapy and Rehabilitation ,Cochrane Library ,law.invention ,Systematic review ,Nursing ,Randomized controlled trial ,Rehabilitation Research ,Research Design ,law ,Evidence-Based Practice ,medicine ,Humans ,Psychology - Abstract
Objective To identify, synthesize, and categorize the methodological issues faced by the rehabilitation field. Data Sources A scoping review was conducted using studies identified in MEDLINE, the Cochrane Library, EMBASE, Web of Science, Scopus, Physiotherapy Evidence Database, and Google Scholar up to August 2018. Study Selection We included all type of publications describing methodological issues in rehabilitation research where rehabilitation is described as a multimodal process. The methodological issues have been categorized and classified. Data Extraction The synthesis included qualitative and quantitative analysis. To focus the attention on rehabilitation, we post hoc divided in “specific issues” (highly related to, even if not exclusive of, rehabilitation research) and “generic issues” (common in biomedical research). Data Synthesis Seventy-one publications were included: 68% were narrative reviews, 15% systematic reviews, 7% editorials, 4% meta-epidemiologic studies, and 5% others. Specific methodological issues include the following: problematic application of randomized controlled trials (32%), absent definition of core outcome sets (28%), poor interventions description (22%), weak methodological (conducting) and reporting quality (21%), scarce clinical practice applicability (14%), lack of blinding assessor (10%), inadequate randomization methods or inadequate allocation concealment (8%), and inadequate participants description and recruitment (8%). “Generic” issues included the following: data and statistical description (31%), authors’ methodological training (7%), peer review process (6%, n=4), funding declaration (6%), ethical statement (3%), protocol registration (3%), and conflict of interest declaration (1%). Conclusions Methodological and reporting issues might influence the quality of the evidence produced in rehabilitation research. The next steps to move forward in the field of rehabilitation could be to evaluate the influence of all these issues on the validity of trial results through meta-epidemiologic studies and to develop specific checklists to provide guidance to authors to improve the reporting and conduct of trials in this field.
- Published
- 2021
12. 57 The family experience of the Autism Spectrum Disorder diagnostic conference: A qualitative meta-synthesis
- Author
-
Kassi Boyd, Shanon Phelan, Alexandra Jackman, Lisa Tjosvold, and Lonnie Zwaigenbaum
- Subjects
Meta synthesis ,Autism spectrum disorder ,Pediatrics, Perinatology and Child Health ,medicine ,Abstract / Résumés ,medicine.disease ,Psychology ,Clinical psychology - Abstract
Background The Canadian prevalence of Autism Spectrum Disorder (ASD) is one in 66 children affecting many families nationwide. Increasingly, clinicians are tasked with discussing new ASD diagnoses with families; however, many physicians are not comfortable with the conversation, despite self-reported familiarity with ASD. Concurrently, research indicates that families are often dissatisfied with their diagnostic journey, including the diagnostic conversation, which has been described as “profound to almost all parents” (Abbott et al., 2012). Given the importance of this moment, we applied a qualitative meta-synthesis design to gain a deeper understanding of the family experience. Meta-synthesis is an emerging field in health sciences, wherein a systematic search strategy is coupled with qualitative analysis. It is valuable for evidence-driven practices and policies as large volumes of qualitative literature are synthesized into actionable concepts. Objectives We aim to describe and appreciate the family experience of an ASD diagnostic conference. We define the diagnostic conference as is the meeting where children, parents, and/or families are told that the child has an ASD diagnosis. Design/Methods We conducted a systematic search to capture relevant qualitative studies, including all qualitative approaches and qualitative components of mixed-methods studies. A search strategy was developed by a medical librarian with systematic review expertise. An initial search of three databases was undertaken to identify keywords. These terms were then used in searching a wider array of pertinent databases. The search was not limited by dates. Applying Saini and Shlonsky’s (2012) meta-synthesis method, included studies’ demographic and contextual data will be extracted. “Findings/Results” sections of included articles will also be extracted and coded by two independent reviewers. Codes will be translated into themes by an interdisciplinary team of two to five reviewers applying an inductive and iterative process, with a critical disability theoretical lens. Themes will be integrated to form an overall synthesis of the family experience of the ASD diagnostic conference. Results In total, 1329 titles/abstracts were reviewed: 23 were selected for inclusion and 24 are pending team discussion. Preliminary analysis reflects shared concepts among included articles such as: provider-family rapport; conflict over who is the expert; comprehensiveness; language; body language; individuals present; physical space; elements of ASD emphasized (positive vs. negative); hope. Most studies were based in North America or Europe with Caucasian participants represented. Mothers were relatively over-represented as participants. In applying a critical disability theoretical lens, initial observations of the language of included studies present a negative framework for meaning making of an ASD diagnosis. Conclusion This meta-synthesis will provide an in-depth appreciation of the family experience of the ASD diagnostic conference and explore the context of published research. In doing so, it may inform individual clinician practices, medical education around communication, and family-centered-care policies.
- Published
- 2020
13. A systematic review of workplace behavioral interventions to promote sleep health in men
- Author
-
Allison Soprovich, Dean T. Eurich, Cherisse L. Seaton, Simon M Rice, Carole James, Cristina M. Caperchione, Mitch J. Duncan, Steven T. Johnson, John L Oliffe, Joan L. Bottorff, and Lisa Tjosvold
- Subjects
Gerontology ,Male ,Stress management ,education.field_of_study ,Population ,MEDLINE ,Psychological intervention ,Cochrane Library ,Occupational safety and health ,03 medical and health sciences ,Behavioral Neuroscience ,0302 clinical medicine ,Workplace health promotion ,Humans ,Health education ,030212 general & internal medicine ,education ,Psychology ,Men's Health ,Sleep ,030217 neurology & neurosurgery ,Occupational Health ,Randomized Controlled Trials as Topic - Abstract
Sleep health is an important aspect of wellbeing and merits incorporation into workplace health promotion programs for employees. Men are a unique population with whom many traditional workplace health promotion programs have had limited success. This systematic review posed the question do workplace health promotion programs improve sleep among men, and what program design features contribute to improving sleep among working men? Databases searched were MEDLINE, EMBASE, the Cochrane Library, CINHAL, Academic Search Complete and Health Source: Nursing/Academic Edition and Google Scholar. Empirical research reporting non-pharmacological behavioral sleep programs and/or interventions for working men were eligible for review. 1049 articles were identified; 15 intervention studies were included: 13 interventions were delivered through workplaces, and two recruited workers to programs delivered outside of work. Interventions incorporated health education, stress reduction/relaxation, and/or physical activity components. Eleven studies reported positive findings for sleep health outcome(s) in men. A moderate level of evidence exists for sleep health programs with physical activity and stress management components. Evidence for the effectiveness of sleep health education programs was mixed. That only one study included a gender-sensitized intervention, where men's preferences shaped the content of a stress-reduction program which resulted in improved sleep quality, attests to the insufficient evidence and lack of gender-specific content and analyses. Next research steps should include considering cultural constructions of masculinity in program design in order to strengthen the appeal and engagement of men, and optimize health benefits for working men.
- Published
- 2019
14. Nursing Staff Time and Care Quality in Long-Term Care Facilities: A Systematic Review
- Author
-
Bing Guo, Sepideh Souri, Lisa Tjosvold, Paula Corabian, Susan Armijo-Olivo, and Rodger Craig
- Subjects
Research design ,media_common.quotation_subject ,Staffing ,Personnel Staffing and Scheduling ,Nursing ,Medicine ,Homes for the Aged ,Humans ,Quality (business) ,media_common ,Aged ,Quality of Health Care ,business.industry ,General Medicine ,Grey literature ,Long-Term Care ,Test (assessment) ,Nursing Homes ,Long-term care ,Workforce ,Observational study ,Nursing Staff ,Geriatrics and Gerontology ,business ,Gerontology ,Delivery of Health Care - Abstract
Background and Objectives In long-term care (LTC) facilities, nursing staff are important contributors to resident care and well-being. Despite this, the relationships between nursing staff coverage, care hours, and quality of resident care in LTC facilities are not well understood and have implications for policy-makers. This systematic review summarizes current evidence on the relationship between nursing staff coverage, care hours, and quality of resident care in LTC facilities. Research Design and Methods A structured literature search was conducted using four bibliographic databases and gray literature sources. Abstracts were screened by two independent reviewers using Covidence software. Data from the included studies were summarized using a pretested extraction form. The studies were critically appraised, and their results were synthesized narratively. Results The systematic searched yielded 15,842 citations, of which 54 studies (all observational) were included for synthesis. Most studies (n = 53, 98%) investigated the effect of nursing staff time on resident care. Eleven studies addressed minimum care hours and quality of care. One study examined the association between different nursing staff coverage models and resident outcomes. Overall, the quality of the included studies was poor. Discussion and Implications Because the evidence was inconsistent and of low quality, there is uncertainty about the direction and magnitude of the association between nursing staff time and type of coverage on quality of care. More rigorously designed studies are needed to test the effects of different cutoffs of care hours and different nursing coverage models on the quality of resident care in LTC facilities.
- Published
- 2018
15. OP71 Evidence Grading Systems Used In Health Technology Assessment Practice
- Author
-
Paula Corabian, Christa Harstall, and Lisa Tjosvold
- Subjects
03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,030503 health policy & services ,Health Policy ,medicine ,Health technology ,Medical physics ,030212 general & internal medicine ,0305 other medical science ,Psychology ,Grading (education) - Abstract
Introduction:To facilitate moving from research findings to conclusions when conducting systematic reviews (SRs) and health technology assessments (HTAs), evidence grading systems (EGSs) have been developed to assess the quality of bodies of evidence and communicate (un)certainty about the effects of evaluated technologies. Use of EGSs has become an essential step in conducting SRs and HTAs and those relying on review conclusions should be aware of EGSs’ potential limitations.Methods:This study aims to identify EGSs used in SR and HTA practice, and summarize findings on their inter-rater reliability (IRR). Relevant sources were searched to identify EGSs used in recently published SRs and IRR studies of available EGSs. Members of the International Network of Agencies for Health Technology Assessment were surveyed regarding their current approaches.Results:Preliminary results indicate that only two conceptually similar EGSs are currently used by several organizations in SR and HTA practice: (i) the Grading of Recommendations Assessment, Development and Evaluation (GRADE) and (ii) the Agency for Healthcare Research and Quality Evidence-based Practice Center Program (AHRQ-EPC). Both approaches emphasize a structured and transparent method. However, results from published IRR studies suggest there is a risk for variability in their application due to researchers’ diverse levels of training and experience in using them, and the complexity and heterogeneity of evidence in SRs.Conclusions:Validated EGSs can play a critical role in whether and how research findings are eventually translated into practice. However, our results indicate a low level of uptake of EGSs in HTA practice. Both currently used EGSs are susceptible to misuse that allows different researchers to grade the same body of evidence differently, and their performance has not been robustly explored in terms of IRR. If these results stand up to replication, one cannot rely on conclusions of published SRs, which has implications for the decisions they inform.
- Published
- 2018
16. Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure
- Author
-
Sumit R. Majumdar, Daniala L. Weir, Ross T. Tsuyuki, Finlay A. McAlister, Lisa Tjosvold, Saskia E. Vanderloo, Dean T. Eurich, and Jeffrey A. Johnson
- Subjects
Comparative Effectiveness Research ,medicine.medical_specialty ,Comorbidity ,law.invention ,Ventricular Dysfunction, Left ,Randomized controlled trial ,law ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Hypoglycemic Agents ,Renal Insufficiency, Chronic ,Intensive care medicine ,Heart Failure ,Ejection fraction ,business.industry ,Contraindications ,medicine.disease ,Metformin ,Hospitalization ,Risk Estimate ,Heart failure ,Cardiology and Cardiovascular Medicine ,business ,Diabetic Angiopathies ,Kidney disease ,Cohort study ,medicine.drug - Abstract
Background— There is an ongoing controversy regarding the safety and effectiveness of metformin in the setting of heart failure (HF). Therefore, we undertook a systematic review of the trial and nontrial evidence for metformin in patients with diabetes mellitus and HF. Methods and Results— We conducted a comprehensive search for controlled studies, evaluating the association between metformin and morbidity and mortality in people with diabetes mellitus and HF. Two reviewers independently identified citations, extracted data, and evaluated quality. Risk estimates were abstracted and pooled where appropriate. As measures of overall safety, we examined all-cause mortality and all-cause hospitalizations. Nine cohort studies were included; no randomized controlled trials were identified. Most (5 of 9) studies were published in 2010 and were of good quality. Metformin was associated with reduced mortality compared with controls (mostly sulfonylurea therapy): 23% versus 37% (pooled adjusted risk estimates: 0.80; 0.74–0.87; I 2 =15%; P I 2 =0%; P =0.34), nor in those with HF and chronic kidney disease (pooled adjusted risk estimate: 0.81; 0.64–1.02; P =0.08). Metformin was associated with a small reduction in all-cause hospitalizations (pooled adjusted risk estimate: 0.93; 0.89–0.98; I 2 =0%; P =0.01). Metformin was not associated with increased risk of lactic acidosis. Conclusions— The totality of evidence indicates that metformin is at least as safe as other glucose-lowering treatments in patients with diabetes mellitus and HF and even in those with reduced left ventricular ejection fraction or concomitant chronic kidney disease. Until trial data become available, metformin should be considered the treatment of choice for patients with diabetes mellitus and HF.
- Published
- 2013
17. The Nature and Influence of Pharmaceutical Industry Involvement in Asthma Trials
- Author
-
Brian H. Rowe, Kenneth Bond, Lisa Tjosvold, Catherine Lemière, and Carol Spooner
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Drug Industry ,Alternative medicine ,030204 cardiovascular system & hematology ,Pharmacology ,03 medical and health sciences ,Diseases of the respiratory system ,0302 clinical medicine ,Combined treatment ,Adrenal Cortex Hormones ,Administration, Inhalation ,medicine ,Humans ,030212 general & internal medicine ,Intensive care medicine ,Pharmaceutical industry ,Asthma ,Clinical Trials as Topic ,RC705-779 ,Conflict of Interest ,business.industry ,Publication bias ,medicine.disease ,3. Good health ,Adrenergic beta-1 Receptor Agonists ,Drug Therapy, Combination ,Original Article ,business - Abstract
BACKGROUND: Pharmaceutical industry-sponsored research has been shown to be biased toward reporting positive results. Frequent industry participation in trials assessing the efficacy of inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination treatment makes assessing industry influence difficult and warrants an assessment of specific potential publication bias in this area.OBJECTIVE: To describe the frequency of industry involvement in ICS/LABA trials and explore associations among significant outcomes, type of industry involvement and type of primary outcome.METHODS: A systematic review of trials comparing ICS/LABA combination therapy with ICS monotherapy for asthma was conducted. Data concerning the type of industry sponsorship, primary outcome and statistical results were collected. Comparisons between type of sponsorship and significant results were analyzed using Pearson’s χ2test and relative risk.RESULTS: Of 91 included studies (median year of publication 2005 [interquartile range 1994 to 2008]), 86 (95%) reported pharmaceutical involvement. Author affiliation was reported in 49 of 86 (57%), and 19 of 86 (22%) were industry-reported trials without full publications. The remainder were published journal articles. Studies with a first or senior author affiliated with industry were 1.5 times more likely to report statistically significant results for the primary outcome compared with studies with other types of industry involvement. Pulmonary measures were 1.5 times more likely to be statistically significant than were measures of asthma control.CONCLUSIONS: The potential biases identified were consistent with other research focused on author role and industry involvement, and suggest that degree of bias may vary with type of affiliation.
- Published
- 2012
18. VP200 Untangling What Information Specialists Should Document and Report
- Author
-
Dagmara Chojecki and Lisa Tjosvold
- Subjects
010104 statistics & probability ,03 medical and health sciences ,0302 clinical medicine ,Health Policy ,030212 general & internal medicine ,0101 mathematics ,Psychology ,01 natural sciences - Abstract
INTRODUCTION:Thorough documentation and clear reporting are essential when conducting a comprehensive literature search for a health technology assessment (HTA) or systematic review. The ultimate goal of this process is transparency and reproducibility with the added benefit of increasing the reader's confidence in the research. Thorough documentation of the search also allows for critical appraisal of the methodology used and facilitates future updating of a review (1,2).It has been found that large numbers of systematic review searches are inadequately documented and there is little consensus on best practices for reporting standards (3).As part of the SuRe Info Project, we conducted a review of all current reporting standards relevant to HTAs and systematic reviews in addition to looking at the published literature on this topic in order to synthesize the evidence in this area and create a standard set of agreed upon recommendations.METHODS:We conducted a comprehensive search of Medline, Embase, and LISA (Library & Info Studies Abstracts) databases. We also examined the Equator Network (http://www.equator-network.org/) website. Reference lists of included studies and reporting guidelines were also consulted. Eleven reporting guidelines and eight studies were included in the review by two independent reviewers. Anything published before 2006, that was not a research article (other than the guidelines), and/or that did not provide new recommendations (that is, a review of another set of recommendations) was excluded.RESULTS:After collecting data on the suggested reporting elements described in the literature, we pooled our results to create an overarching list of the most commonly recommended elements to describe and the most commonly recommended methods to use when documenting a comprehensive search. Not only did these elements pertain to documenting the search strategy for the final report, but they also pertained to the protocol and the abstract of a review.CONCLUSIONS:It is hoped that this overview of the literature and compilation of the evidence will clarify some of the confusion that seems to exist when documenting and reporting searches and perhaps it will even help to reduce the existence of poorly described strategies in the research literature.
- Published
- 2017
19. Instruments to Detect Alcohol and Other Drug Misuse in the Emergency Department: A Systematic Review
- Author
-
T. Cameron Wild, Neelam Mabood, Nicole Ata, Rebecca Gokiert, Lisa Hartling, Samina Ali, Kathryn Dong, Lisa Tjosvold, Ben Vandermeer, and Amanda S Newton
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Substance-Related Disorders ,MEDLINE ,Validity ,Alcohol abuse ,Poison control ,Context (language use) ,PsycINFO ,Young Adult ,Humans ,Medicine ,Child ,business.industry ,Reproducibility of Results ,Emergency department ,medicine.disease ,Substance Abuse Detection ,Alcoholism ,Family medicine ,Pediatrics, Perinatology and Child Health ,Female ,Medical emergency ,Brief intervention ,Emergency Service, Hospital ,business - Abstract
CONTEXT: Alcohol and other drug (AOD) misuse by youth is a significant public health concern. Unanticipated treatment for AOD-related morbidities is often sought in hospital emergency departments (EDs). Screening instruments that rapidly identify patients who require further diagnostic evaluation and/or brief intervention are critically important. OBJECTIVE: To summarize evidence on screening instruments that can assist emergency care clinicians in identifying AOD misuse in pediatric patients. METHODS: Fourteen electronic databases (including Medline, Embase, and PsycINFO) and reference screening were used. Psychometric and prospective diagnostic studies were selected if the instrument focused on detecting AOD misuse in patients aged 21 years or younger in the ED. Two reviewers independently assessed quality and extracted data. Validity and reliability data were collected for psychometric studies. Instrument performance was assessed by using sensitivity, specificity, and positive (LR+) and negative (LR−) likelihood ratios. Meta-analysis was not possible because of clinical and measurement heterogeneity. RESULTS: Of the 1545 references initially identified, 6 studies met inclusion criteria; these studies evaluated 11 instruments for universal or targeted screening of alcohol misuse. Instruments based on diagnostic criteria for AOD disorders were effective in detecting alcohol abuse and dependence (sensitivity: 0.88; specificity: 0.90; LR+: 8.80) and cannabis use disorder (sensitivity: 0.96; specificity: 0.86; LR+: 6.83). CONCLUSIONS: On the basis of the current evidence, we recommend that emergency care clinicians use a 2-question instrument for detecting youth alcohol misuse and a 1-question instrument for detecting cannabis misuse. Additional research is required to definitively answer whether these tools should be used as targeted or universal screening approaches in the ED.
- Published
- 2011
20. A systematic review of interventions to support siblings of children with chronic illness or disability
- Author
-
Amanda S Newton, Andrea Milne, Lisa Tjosvold, Lisa Hartling, Dawn Wrightson, and Jennifer Gallivan
- Subjects
medicine.medical_specialty ,business.industry ,Psychological intervention ,Interpersonal relationship ,Data extraction ,Pediatrics, Perinatology and Child Health ,Needs assessment ,medicine ,Anxiety ,Improved mood ,Sibling ,medicine.symptom ,Psychiatry ,business ,Psychosocial - Abstract
Aim: Chronic illness or disability in children can have a deleterious effect on the psychosocial health of well siblings. This systematic review synthesised evidence from studies evaluating sibling-oriented care aimed at improving behavioural and emotional outcomes in well siblings of children with chronic illness or disability. Methods: Twenty electronic databases were searched. Study selection, data extraction and assessment of methodological quality were performed by two independent reviewers. Results: Five controlled and nine uncontrolled studies were included. In higher-quality controlled trials, benefits of sibling-oriented care included reduced anxiety, improved mood and behavioural adjustment; however, these findings were not consistently demonstrated across studies. Study differences made it difficult to determine which sibling care features were most salient. Conclusions: Study findings highlight the potential for enhancing emotional and behavioural outcomes in well siblings. Future evaluations need to clearly identify the intended purpose of the care (what improvements are intended) and which types of siblings are most likely to benefit. This approach may yield more consistent and clinically important results.
- Published
- 2010
21. Systematic review data extraction: cross-sectional study showed that experience did not increase accuracy
- Author
-
Ben Vandermeer, Lisa Tjosvold, Terry P. Klassen, Nina Buscemi, Jennifer Horton, and Lisa Hartling
- Subjects
Evidence-Based Medicine ,Time Factors ,Operations research ,Epidemiology ,Cross-sectional study ,business.industry ,Extraction (chemistry) ,Review Literature as Topic ,Reference Standards ,Professional Competence ,Systematic review ,Primary outcome ,Data extraction ,Sleep Initiation and Maintenance Disorders ,Meta-analysis ,Statistics ,Humans ,Medicine ,Experience level ,Epidemiologic Methods ,business - Abstract
Objective This study assessed the impact of systematic review and data extraction experience on the accuracy and efficiency of data extraction in systematic reviews. Study Design and Setting We conducted a prospective cross-sectional study from October to December 2006. Participants were classified as having minimal, moderate, or substantial experience in systematic reviews and data extraction. Three studies on insomnia treatment were extracted. Our primary outcome was the accuracy of data extraction. Data sets of each experience level were analyzed for errors in data extraction and results of meta-analyses. Additionally, the time required for completion of data extraction was compared. Results Error rates were similar across the various levels of experience and ranged from 28.3% to 31.2%. Mean rates for errors of omission (11.3–16.4%) were generally lower than those for errors of inaccuracy (13.9–17.9%). There were no significant differences in error rates or accuracy of meta-analysis results between groups. Time required approached significance, with minimally experienced participants requiring the most time. Conclusion Overall, there were high error rates by participants at all experience levels; however, time required for extraction tended to decrease with experience. These results illustrate the need to develop strategies aimed at mastery of data extraction, rather than reliance on previous data extraction experience alone.
- Published
- 2010
22. Music for medical indications in the neonatal period: a systematic review of randomised controlled trials
- Author
-
Mehaboob Shaik, Lisa Tjosvold, Manoj Kumar, Yuanyuan Liang, Robin Leicht, and Lisa Hartling
- Subjects
Pediatrics ,medicine.medical_specialty ,Heel ,Music psychology ,business.industry ,Infant, Newborn ,Psychological intervention ,MEDLINE ,Pain ,Obstetrics and Gynecology ,General Medicine ,Jadad scale ,medicine.anatomical_structure ,Lung disease ,Sucking Behavior ,Pediatrics, Perinatology and Child Health ,Pacifier ,medicine ,Physical therapy ,Humans ,business ,Music ,Period (music) ,Randomized Controlled Trials as Topic - Abstract
Objective: To conduct a systematic review of the efficacy of music for medical indications in term or preterm neonates. Methods: We searched 17 electronic databases, subject bibliographies, reference lists and trials registries. Two reviewers independently screened studies for inclusion, assessed methodological quality, and extracted data. Meta-analysis was not feasible due to heterogeneity in outcomes so a qualitative analysis is presented. Results: Nine randomised trials were included. The methodological quality was generally poor (median Jadad score = 1). The outcomes most commonly reported were physiological measures (heart rate (HR), respiratory rate, oxygen saturation (Sao 2 )), behavioural state and pain. Six studies evaluated music for the painful procedures circumcision (three trials) and heel prick (three trials). For circumcisions, one high quality pilot study (n = 23) showed benefits of music for the outcomes of HR, Sao 2 and pain, while two low quality studies showed no difference. For heel prick, three low quality studies provided some evidence that music may be beneficial primarily for measures of behaviour and pain. The remaining studies evaluated the use of music in preterm infants to improve physiological and behavioural parameters (n = 31; benefits observed for behavioural parameters), to reinforce non-nutritive sucking via use of a pacifier activated lullaby (n = 32; significant increase in feeding rates), and to influence physiological stability and behaviours in infants with chronic lung disease (n = 22; no significant differences for outcomes assessed). Conclusions: The heterogeneity in study populations, interventions and outcomes precludes definitive conclusions around efficacy. There is preliminary evidence for some therapeutic benefits of music for specific indications; however, these findings need to be confirmed in methodologically rigorous trials.
- Published
- 2009
23. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE
- Author
-
Nicole Boluyt, Carol Lefebvre, Lisa Tjosvold, Terry P. Klassen, Martin Offringa, Amsterdam Public Health, Neonatology, and Other Research
- Subjects
Pediatrics ,medicine.medical_specialty ,Evidence-based practice ,Adolescent ,MEDLINE ,Child Welfare ,Information Storage and Retrieval ,Sensitivity and Specificity ,Child health ,User-Computer Interface ,medicine ,Humans ,Guideline development ,Medical physics ,Child ,Subject Headings ,Evidence-Based Medicine ,business.industry ,Public health ,Infant, Newborn ,Infant ,Evidence-based medicine ,Review Literature as Topic ,Identification (information) ,Systematic review ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,business - Abstract
Objective To determine the sensitivity and precision of existing search strategies for retrieving child health systematic reviews in MEDLINE using PubMed. Design Filter (diagnostic) accuracy study. We identified existing search strategies for systematic reviews, combined them with a filter that identifies articles relevant to child health, and applied the combination in MEDLINE to a reference set of child health systematic reviews. Main Outcome Measures Total number of records retrieved, sensitivity, and precision. Results We tested 9 search filters. Sensitivity of the systematic review filters combined with the child filter ranged from 68% to 96%; sensitivity of the child filter alone was 98%. The number of records retrieved with PubMed (limited to January 1990-January 2006) by the systematic review filters combined with the child filter ranged from 7861 to 618 053. Precision for the combined filters ranged from 2% to 52%. Because of poor reporting of specific systematic review criteria in both titles and abstracts, in 25% of the records screened we were unsure whether the article concerned a systematic review according to our definition. Conclusions The high numbers of records yielded by sensitive search strategies and the low precision threaten the use of systematic reviews for clinical decision making and guideline development. Reporting of specific systematic review criteria in titles and abstracts is poor, and reporting recommendations given by Quality of Reporting of Meta-analyses (QUOROM) should be used more strictly. To make identification using MEDLINE easier, there is an urgent need to set minimal criteria that any review should fulfill for it to be indexed as a systematic review.
- Published
- 2008
24. Single data extraction generated more errors than double data extraction in systematic reviews
- Author
-
Nina Buscemi, Ben Vandermeer, Lisa Tjosvold, Lisa Hartling, and Terry P. Klassen
- Subjects
Epidemiology ,Group method of data handling ,business.industry ,Extraction (chemistry) ,Information Storage and Retrieval ,Pilot Projects ,computer.software_genre ,Time ,Extractor ,Data set ,Review Literature as Topic ,McNemar's test ,Systematic review ,Data extraction ,Data Interpretation, Statistical ,Meta-analysis ,Statistics ,Humans ,Medicine ,Single-Blind Method ,Data mining ,business ,computer - Abstract
Background and Objective To conduct a pilot study to compare the frequency of errors that accompany single vs. double data extraction, compare the estimate of treatment effect derived from these methods, and compare the time requirements for these methods. Methods Reviewers were randomized to the role of data extractor or data verifier, and were blind to the study hypothesis. The frequency of errors associated with each method of data extraction was compared using the McNemar test. The data set for each method was used to calculate an efficacy estimate by each method, using standard meta-analytic techniques. The time requirement for each method was compared using a paired t-test. Results Single data extraction resulted in more errors than double data extraction (relative difference: 21.7%, P = .019). There was no substantial difference between methods in effect estimates for most outcomes. The average time spent for single data extraction was less than the average time for double data extraction (relative difference: 36.1%, P = .003). Conclusion In the case that single data extraction is used in systematic reviews, reviewers and readers need to be mindful of the possibility for more errors and the potential impact these errors may have on effect estimates.
- Published
- 2006
25. Effect of Vitamin D3 Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis
- Author
-
Isabelle N. Colmers, Lisa Tjosvold, Alun L. Edwards, Jeffrey A. Johnson, Mayer B. Davidson, Joanna Mitri, Anastassios G. Pittas, David A. Hanley, Jennifer C Seida, and Sumit R Majumdar
- Subjects
medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,Type 2 diabetes ,medicine.disease ,Special Features ,Biochemistry ,law.invention ,Endocrinology ,Systematic review ,Randomized controlled trial ,law ,Meta-analysis ,Internal medicine ,medicine ,Vitamin D and neurology ,Glucose homeostasis ,Observational study ,Prediabetes ,business - Abstract
Context: Observational studies report consistent associations between low vitamin D concentration and increased glycemia and risk of type 2 diabetes, but results of randomized controlled trials (RCTs) are mixed. Objective: The objective of the study was to systematically review RCTs that report on the effects of vitamin D supplementation on glucose homeostasis or diabetes prevention. Data Sources: Sources of data for the study were MEDLINE, EMBASE, SCOPUS, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Health Technology Assessment, and Science Citation Index from inception to June 2013. Study Selection: Study selection was trials that compared vitamin D3 supplementation with placebo or a non-vitamin D supplement in adults with normal glucose tolerance, prediabetes, or type 2 diabetes. Data Extraction and Synthesis: Two reviewers collected data and assessed trial quality using the Cochrane Risk of Bias tool. Random-effects models were used to estimate mean differences...
- Published
- 2014
26. Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis
- Author
-
Gaetanne K. Murphy, Finlay A. McAlister, Daniala L. Weir, Dean T. Eurich, and Lisa Tjosvold
- Subjects
Gerontology ,Adult ,Rural Population ,medicine.medical_specialty ,Canada ,Databases, Factual ,Urban Population ,Ambulatory care ,Risk Factors ,Environmental health ,Epidemiology ,medicine ,Drug utilization ,Humans ,Medication adherence ,Aged ,Aged, 80 and over ,business.industry ,Public Health, Environmental and Occupational Health ,Australia ,Cardiovascular Agents ,Middle Aged ,Checklist ,United States ,Europe ,Cardiovascular diseases ,Diabetes Mellitus, Type 2 ,Meta-analysis ,Cardiovascular agent ,Patient Compliance ,Observational study ,Female ,Rural area ,Biostatistics ,business ,Research Article - Abstract
Background Rural residents face numerous barriers to healthcare access and studies suggest poorer health outcomes for rural patients. Therefore we undertook a systematic review to determine if cardiovascular medication utilization and adherence patterns differ for rural versus urban patients. Methods A comprehensive search of major electronic datasets was undertaken for controlled clinical trials and observational studies comparing utilization or adherence to cardiovascular medications in rural versus urban adults with cardiovascular disease or diabetes. Two reviewers independently identified citations, extracted data, and evaluated quality using the STROBE checklist. Risk estimates were abstracted and pooled where appropriate using random effects models. Methods and reporting were in accordance with MOOSE guidelines. Results Fifty-one studies were included of fair to good quality (median STROBE score 17.5). Although pooled unadjusted analyses suggested that patients in rural areas were less likely to receive evidence-based cardiovascular medications (23 studies, OR 0.88, 95% CI 0.79, 0.98), pooled data from 21 studies adjusted for potential confounders indicated no rural–urban differences (adjusted OR 1.02, 95% CI 0.91, 1.13). The high heterogeneity observed (I2 = 97%) was partially explained by treatment setting (hospital, ambulatory care, or community-based sample), age, and disease. Adherence did not differ between urban versus rural patients (3 studies, OR 0.94, 95% CI 0.39, 2.27, I2 = 91%). Conclusions We found no consistent differences in rates of cardiovascular medication utilization or adherence among adults with cardiovascular disease or diabetes living in rural versus urban settings. Higher quality evidence is needed to determine if differences truly exist between urban and rural patients in the use of, and adherence to, evidence-based medications.
- Published
- 2013
27. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis
- Author
-
Wendy I. Sligl, Lisa Tjosvold, Thomas J. Marrie, Leyla Asadi, Dean T. Eurich, and Sumit R. Majumdar
- Subjects
medicine.medical_specialty ,business.industry ,Critically ill ,Critical Illness ,MEDLINE ,Critical Care and Intensive Care Medicine ,medicine.disease ,Anti-Bacterial Agents ,Community-Acquired Infections ,Pneumonia ,Community-acquired pneumonia ,Meta-analysis ,Critical illness ,Pneumonia, Bacterial ,Medicine ,Humans ,Macrolides ,business ,Intensive care medicine - Abstract
Some studies suggest better outcomes with macrolide therapy for critically ill patients with community-acquired pneumonia. To further explore this, we performed a systematic review of studies with mortality endpoints that compared macrolide therapy with other regimens in critically ill patients with community-acquired pneumonia.Studies were identified via electronic databases, grey literature, and conference proceedings through May 2013.Using prespecified criteria, two reviewers selected studies; studies of outpatients and hospitalized noncritically ill patients were excluded.Two reviewers extracted data and evaluated bias using the Newcastle-Ottawa Scale. Random effects models were used to generate pooled risk ratios and evaluate heterogeneity (I).Twenty-eight observational studies (no randomized control trials) were included. Average age ranged from 58 to 78 years and 14-49% were women. In our primary analysis of 9,850 patients, macrolide use was associated with statistically significant lower mortality compared with nonmacrolides (21% [846 of 4,036 patients] vs 24% [1,369 of 5,814]; risk ratio, 0.82; 95% CI, 0.70-0.97; p = 0.02; I = 63%). When macrolide monotherapy was excluded, the macrolide mortality benefit was maintained (21% [737 of 3,447 patients] vs 23% [1,245 of 5,425]; risk ratio, 0.84; 95% CI, 0.71-1.00; p = 0.05; I = 60%). When broadly guideline-concordant regimens were compared, there was a trend to improved mortality and heterogeneity was reduced (20% [511 of 2,561 patients] mortality with beta-lactam/macrolide therapy vs 23% [386 of 1,680] with beta-lactam/fluoroquinolone; risk ratio, 0.83; 95% CI, 0.67-1.03; p = 0.09; I = 25%). When adjusted risk estimates were pooled from eight studies, macrolide therapy was still associated with a significant reduction in mortality (risk ratio, 0.75; 95% CI, 0.58-0.96; p = 0.02; I = 57%).In observational studies of almost 10,000 critically ill patients with community-acquired pneumonia, macrolide use was associated with a significant 18% relative (3% absolute) reduction in mortality compared with nonmacrolide therapies. After pooling data from studies that provided adjusted risk estimates, an even larger mortality reduction was observed. These results suggest that macrolides be considered first-line combination treatment in critically ill patients with community-acquired pneumonia and support current guidelines.
- Published
- 2013
28. Oral baclofen for the management of spasticity in children with cerebral palsy
- Author
-
John Andersen, Lisa Hartling, and Lisa Tjosvold
- Published
- 2013
29. Brief emergency department interventions for youth who use alcohol and other drugs: a systematic review
- Author
-
Lisa Hartling, Amanda S Newton, Lisa Tjosvold, Nicole Ata, Ben Vandermeer, Neelam Mabood, Kathryn Dong, T. Cameron Wild, Samina Ali, and Rebecca Gokiert
- Subjects
Pediatrics ,medicine.medical_specialty ,Automobile Driving ,Adolescent ,Substance-Related Disorders ,media_common.quotation_subject ,Motivational interviewing ,Poison control ,Comorbidity ,Violence ,law.invention ,Young Adult ,Randomized controlled trial ,Bias ,law ,Injury prevention ,Dangerous Behavior ,Medicine ,Humans ,Psychiatry ,Child ,media_common ,Clinical Trials as Topic ,Motivation ,business.industry ,Alcohol Abstinence ,General Medicine ,Abstinence ,Patient Acceptance of Health Care ,Databases, Bibliographic ,Clinical trial ,Alcoholism ,Treatment Outcome ,Adolescent Behavior ,Epidemiologic Research Design ,Pediatrics, Perinatology and Child Health ,Emergency Medicine ,Psychotherapy, Brief ,Brief intervention ,business ,Emergency Service, Hospital ,Alcohol-Related Disorders - Abstract
OBJECTIVE: Brief intervention (BI) is recommended for use with youth who use alcohol and other drugs. Emergency departments (EDs) can provide BIs at a time directly linked to harmful and hazardous use. The objective of this systematic review was to determine the effectiveness of ED-based BIs. METHODS: We searched 14 electronic databases, a clinical trial registry, conference proceedings, and study references. We included randomized controlled trials with youth 21 years or younger. Two reviewers independently selected studies and assessed methodological quality. One reviewer extracted and a second verified data. We summarized findings qualitatively. RESULTS: Two trials with low risk of bias, 2 trials with unclear risk of bias, and 5 trials with high risk of bias were included. Trials evaluated targeted BIs for alcohol-positive (n = 3) and alcohol/other drug-positive youth (n = 1) and universal BIs for youth reporting recent alcohol (n = 4) or cannabis use (n = 1). Few differences were found in favor of ED-based BIs, and variation in outcome measurement and poor study quality precluded firm conclusions for many comparisons. Universal and targeted BIs did not significantly reduce alcohol use more than other care. In one targeted BI trial with high risk of bias, motivational interviewing (MI) that involved parents reduced drinking quantity per occasion and high-volume alcohol use compared with MI that was delivered to youth only. Another trial with high risk of bias reported an increase in abstinence and reduction in physical altercations when youth received peer-delivered universal MI for cannabis use. In 2 trials with unclear risk of bias, MI reduced drinking and driving and alcohol-related injuries after the ED visit. Computer-based MI delivered universally in 1 trial with low risk of bias reduced alcohol-related consequences 6 months after the ED visit. CONCLUSIONS: Clear benefits of using ED-based BI to reduce alcohol and other drug use and associated injuries or high-risk behaviours remain inconclusive because of variation in assessing outcomes and poor study quality. Language: en
- Published
- 2013
30. A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout
- Author
-
Natasha Wiebe, Arash Ehteshami-Afshar, Joanne Homik, Lisa Tjosvold, Labib Faruque, and Marcello Tonelli
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Gout ,Allopurinol ,Subgroup analysis ,Hyperuricemia ,Gout Suppressants ,Febuxostat ,Rheumatology ,Internal medicine ,medicine ,Humans ,Adverse effect ,business.industry ,nutritional and metabolic diseases ,medicine.disease ,Confidence interval ,Surgery ,Uric Acid ,Thiazoles ,Anesthesiology and Pain Medicine ,Treatment Outcome ,Meta-analysis ,Relative risk ,business ,medicine.drug - Abstract
To evaluate the safety and efficacy of febuxostat compared to allopurinol for the treatment of chronic gout.We did a systematic review and meta-analysis of randomized and non-randomized controlled trials that compared oral febuxostat to oral allopurinol for treatment of chronic gout. Two reviewers independently selected studies, assessed study quality, and extracted data. Risk ratios (RR) were calculated with random effects and were reported with corresponding 95% confidence intervals (CI).From 1076 potentially relevant citations, 7 studies and 25 associated publications met inclusion criteria; 5 studies were ultimately included in the analysis. Febuxostat did not reduce the risk of gout flares compared with allopurinol (RR = 1.16, 95% CI = 1.03-1.30, I(2) = 44%). Overall, the risk of any adverse event was lower in febuxostat recipients compared to allopurinol (RR = 0.94, 95% CI = 0.90-0.99, I(2) = 13%). Patients receiving febuxostat were more likely to achieve a serum uric acid of6 mg/dl than allopurinol recipients (RR = 1.56, 95% CI = 1.22-2.00, I(2) = 92%). Subgroup analysis did not indicate any significant difference between high- and low-dose febuxostat on the risk of gout flares.Although febuxostat was associated with higher likelihood of achieving a target serum uric acid level of6 mg/dl, there was significant heterogeneity in the pooled results. There was no evidence that febuxostat is superior to allopurinol for clinically relevant outcomes. Given its higher cost, febuxostat should not be routinely used for chronic gout.
- Published
- 2013
31. Glucocorticoids for acute viral bronchiolitis in infants and young children
- Author
-
Ben Vandermeer, Amy C Plint, Ricardo M. Fernandes, Terry P. Klassen, Liza Bialy, Hema Patel, Lisa Hartling, Lisa Tjosvold, David W. Johnson, and Repositório da Universidade de Lisboa
- Subjects
Pediatrics ,medicine.medical_specialty ,Epinephrine ,Acute viral bronchiolitis ,Placebo ,Dexamethasone ,law.invention ,Randomized controlled trial ,Ambulatory care ,law ,Ambulatory Care ,Medicine ,Bronchiolitis, Viral ,Humans ,Pharmacology (medical) ,Clinical severity ,Adverse effect ,Glucocorticoids ,Randomized Controlled Trials as Topic ,Respiratory Sounds ,First episode ,business.industry ,Infant, Newborn ,Infant ,General Medicine ,medicine.disease ,Hospitalization ,Clinical question ,Bronchiolitis ,Relative risk ,Meta-analysis ,Acute Disease ,Number needed to treat ,business ,medicine.drug - Abstract
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd., Background: Previous systematic reviews have not shown clear benefit of glucocorticoids for acute viral bronchiolitis, but their use remains considerable. Recent large trials add substantially to current evidence and suggest novel glucocorticoid-including treatment approaches. Objectives: To review the efficacy and safety of systemic and inhaled glucocorticoids in children with acute viral bronchiolitis. Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2012, Issue 12), MEDLINE (1950 to January week 2, 2013), EMBASE (1980 to January 2013), LILACS (1982 to January 2013), Scopus® (1823 to January 2013) and IRAN MedEx (1998 to November 2009). Selection criteria: Randomised controlled trials (RCTs) comparing short-term systemic or inhaled glucocorticoids versus placebo or another intervention in children under 24 months with acute bronchiolitis (first episode with wheezing). Our primary outcomes were: admissions by days 1 and 7 for outpatient studies; and length of stay (LOS) for inpatient studies. Secondary outcomes included clinical severity parameters, healthcare use, pulmonary function, symptoms, quality of life and harms. Data collection and analysis: Two authors independently extracted data on study and participant characteristics, interventions and outcomes. We assessed risk of bias and graded strength of evidence. We meta-analysed inpatient and outpatient results separately using random-effects models. We pre-specified subgroup analyses, including the combined use of bronchodilators used in a protocol. Main results: We included 17 trials (2596 participants); three had low overall risk of bias. Baseline severity, glucocorticoid schemes, comparators and outcomes were heterogeneous. Glucocorticoids did not significantly reduce outpatient admissions by days 1 and 7 when compared to placebo (pooled risk ratios (RRs) 0.92; 95% confidence interval (CI) 0.78 to 1.08 and 0.86; 95% CI 0.7 to 1.06, respectively). There was no benefit in LOS for inpatients (mean difference -0.18 days; 95% CI -0.39 to 0.04). Unadjusted results from a large factorial low risk of bias RCT found combined high-dose systemic dexamethasone and inhaled epinephrine reduced admissions by day 7 (baseline risk of admission 26%; RR 0.65; 95% CI 0.44 to 0.95; number needed to treat 11; 95% CI 7 to 76), with no differences in short-term adverse effects. No other comparisons showed relevant differences in primary outcomes. Authors' conclusions: Current evidence does not support a clinically relevant effect of systemic or inhaled glucocorticoids on admissions or length of hospitalisation. Combined dexamethasone and epinephrine may reduce outpatient admissions, but results are exploratory and safety data limited. Future research should further assess the efficacy, harms and applicability of combined therapy.
- Published
- 2013
32. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis
- Author
-
Thomas J. Marrie, Leyla Asadi, Isabelle N. Colmers, Wendy I. Sligl, Sumit R. Majumdar, Lisa Tjosvold, and Dean T. Eurich
- Subjects
Microbiology (medical) ,Adult ,Male ,medicine.medical_specialty ,Pediatrics ,medicine.drug_class ,Concordance ,Antibiotics ,Community-acquired pneumonia ,Internal medicine ,medicine ,Pneumonia, Bacterial ,Humans ,Survival analysis ,Aged ,Randomized Controlled Trials as Topic ,Aged, 80 and over ,business.industry ,Guideline ,Middle Aged ,medicine.disease ,Survival Analysis ,Confidence interval ,Anti-Bacterial Agents ,Community-Acquired Infections ,Pneumonia ,Infectious Diseases ,Treatment Outcome ,Meta-analysis ,Female ,Macrolides ,business - Abstract
Macrolides are used to treat pneumonia despite increasing antimicrobial resistance. However, the immunomodulatory properties of macrolides may have a favorable effect on pneumonia outcomes. Therefore, we systematically reviewed all studies of macrolide use and mortality among patients hospitalized with community-acquired pneumonia (CAP).All randomized control trials (RCTs) and observational studies comparing macrolides to other treatment regimens in adults hospitalized with CAP were identified through electronic databases and gray literature searches. Primary analysis examined any macrolide use and mortality; secondary analysis compared Infectious Diseases Society of America/American Thoracic Society guideline-concordant macrolide/beta-lactam combinations vs respiratory fluoroquinolones. Random effects models were used to generate pooled risk ratios (RRs) and evaluate heterogeneity (I(2)).We included 23 studies and 137,574 patients. Overall, macrolide use was associated with a statistically significant mortality reduction compared with nonmacrolide use (3.7% [1738 of 47,071] vs 6.5% [5861 of 90,503]; RR, 0.78; 95% confidence interval [CI], .64-.95; P = .01; I(2)= 85%). There was no survival advantage and heterogeneity was reduced when analyses were restricted to RCTs (4.6% [22 of 479] vs 4.1% [25 of 613]; RR, 1.13; 95% CI, .65-1.98; P = .66; I(2)= 0%) or to patients treated with guideline-concordant antibiotics (macrolide/beta-lactam, 5.3% [297 of 5574] vs respiratory fluoroquinolones, 5.8% [408 of 7050]; RR, 1.17; 95% CI, .91-1.50; P = .22; I(2)= 43%).In hospitalized patients with CAP, macrolide-based regimens were associated with a significant 22% reduction in mortality compared with nonmacrolides; however, this benefit did not extend to patients studied in RCTs or patients that received guideline-concordant antibiotics. Our findings suggest guideline concordance is more important than choice of antibiotic when treating CAP.
- Published
- 2012
33. Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies
- Author
-
J. A. Johnson, Isabelle N. Colmers, Samantha L. Bowker, and Lisa Tjosvold
- Subjects
Oncology ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Type 2 diabetes ,Cohort Studies ,Prostate cancer ,Endocrinology ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Pancreatic cancer ,Neoplasms ,Internal Medicine ,medicine ,Humans ,Insulin ,business.industry ,Insulin glargine ,Cancer ,General Medicine ,medicine.disease ,Diabetes Mellitus, Type 2 ,Meta-analysis ,Case-Control Studies ,business ,medicine.drug - Abstract
Aims To determine whether data from observational studies supports the hypothesis of an increased risk of overall and site-specific cancer among individuals with diabetes using exogenous insulin therapies. Methods We conducted a comprehensive search of nine key biomedical databases for all years up to December 2011, restricted to the English language. Data from cohort and nested case-control studies were included in random effects meta-analyses of site-specific and overall cancer incidence comparing ever use and new use of: (1) insulin to no insulin and; (2) insulin glargine to other insulins. Results The search yielded 3052 unique citations, of which 19 were selected for inclusion, representing data for 1,332,120 people and 41,947 cancers. Pancreatic cancer risk was increased among new users of insulin (RR: 3.18, 95%CI: 3.27–3.71, I 2 =32%). New use of insulin glargine was associated with an increased risk of pancreatic cancer (RR: 1.63, 95%CI: 1.05–2.51, I 2 =0%) and prostate cancers (RR: 2.68, 95%CI: 1.50–4.79, I 2 =0%) but a decreased risk of colorectal cancer (RR: 0.78, 95%CI: 0.64–0.94, I 2 =15%). Conclusion New use of insulin or insulin glargine was associated with an increased risk of pancreatic cancer, possibly due to reverse causality. New use of insulin glargine was associated with a decreased risk of colorectal cancer but an increased risk of prostate cancer. Our results should be interpreted with caution due to limitations of included studies.
- Published
- 2012
34. Epinephrine for bronchiolitis
- Author
-
Hema Patel, Terry P. Klassen, Amy C Plint, Ricardo M. Fernandes, Lisa Hartling, Ben Vandermeer, Liza Bialy, Lisa Tjosvold, and David W. Johnson
- Subjects
medicine.medical_specialty ,Epinephrine ,Placebo ,law.invention ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Albuterol ,Pharmacology (medical) ,Adverse effect ,Randomized Controlled Trials as Topic ,business.industry ,Infant ,medicine.disease ,Confidence interval ,Bronchodilator Agents ,Bronchiolitis ,Relative risk ,Anesthesia ,Meta-analysis ,Acute Disease ,business ,medicine.drug - Abstract
Background Bronchodilators are commonly used for acute bronchiolitis, despite uncertain effectiveness. Objectives To examine the efficacy and safety of epinephrine in children less than two with acute viral bronchiolitis. Search methods We searched CENTRAL (2010, Issue 3) which contains the Acute Respiratory Infections Group's Specialized Register, MEDLINE (1950 to September Week 2, 2010), EMBASE (1980 to September 2010), Scopus (1823 to September 2010), PubMed (March 2010), LILACS (1985 to September 2010) and Iran MedEx (1998 to September 2010). Selection criteria We included randomized controlled trials comparing epinephrine to placebo or another intervention involving children less than two years with acute viral bronchiolitis. Studies were included if the trials presented data for at least one quantitative outcome of interest. We selected primary outcomes a priori, based on clinical relevance: rate of admission by days one and seven of presentation for outpatients, and length of stay (LOS) for inpatients. Secondary outcomes included clinical severity scores, pulmonary function, symptoms, quality of life and adverse events. Data collection and analysis Two review authors independently screened the searches, applied inclusion criteria, assessed risk of bias and graded the evidence. We conducted separate analyses for different comparison groups (placebo, non-epinephrine bronchodilators, glucocorticoids) and for clinical setting (inpatient, outpatient). Main results We included 19 studies (2256 participants). Epinephrine versus placebo among outpatients showed a significant reduction in admissions at Day 1 (risk ratio (RR) 0.67; 95% confidence interval (CI) 0.50 to 0.89) but not at Day 7 post-emergency department visit. There was no difference in LOS for inpatients. Epinephrine versus salbutamol showed no differences among outpatients for admissions at Day 1 or 7. Inpatients receiving epinephrine had a significantly shorter LOS compared to salbutamol (mean difference -0.28; 95% CI -0.46 to -0.09). One large RCT showed a significantly shorter admission rate at Day 7 for epinephrine and steroid combined versus placebo (RR 0.65; 95% CI 0.44 to 0.95). There were no important differences in adverse events. Authors' conclusions This review demonstrates the superiority of epinephrine compared to placebo for short-term outcomes for outpatients, particularly in the first 24 hours of care. Exploratory evidence from a single study suggests benefits of epinephrine and steroid combined for later time points. More research is required to confirm the benefits of combined epinephrine and steroids among outpatients. There is no evidence of effectiveness for repeated dose or prolonged use of epinephrine or epinephrine and dexamethasone combined among inpatients.
- Published
- 2011
35. A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007
- Author
-
Lisa Tjosvold, Denise Thomson, Terry P. Klassen, Lisa Hartling, Sarah Curtis, Ben Vandermeer, Andrea Milne, and Michele P Hamm
- Subjects
Research design ,medicine.medical_specialty ,Pediatrics ,Psychological intervention ,Guidelines as Topic ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,Correspondence ,Humans ,Medicine ,Pediatrics, Perinatology, and Child Health ,030212 general & internal medicine ,Child ,Adverse effect ,Randomized Controlled Trials as Topic ,Publishing ,Response rate (survey) ,Protocol (science) ,business.industry ,Gold standard ,lcsh:RJ1-570 ,Consolidated Standards of Reporting Trials ,lcsh:Pediatrics ,3. Good health ,Research Design ,Pediatrics, Perinatology and Child Health ,Physical therapy ,Guideline Adherence ,business - Abstract
Background Randomized controlled trials (RCTs) are the gold standard for trials assessing the effects of therapeutic interventions; therefore it is important to understand how they are conducted. Our objectives were to provide an overview of a representative sample of pediatric RCTs published in 2007 and assess the validity of their results. Methods We searched Cochrane Central Register of Controlled Trials using a pediatric filter and randomly selected 300 RCTs published in 2007. We extracted data on trial characteristics; outcomes; methodological quality; reporting; and registration and protocol characteristics. Trial registration and protocol availability were determined for each study based on the publication, an Internet search and an author survey. Results Most studies (83%) were efficacy trials, 40% evaluated drugs, and 30% were placebo-controlled. Primary outcomes were specified in 41%; 43% reported on adverse events. At least one statistically significant outcome was reported in 77% of trials; 63% favored the treatment group. Trial registration was declared in 12% of publications and 23% were found through an Internet search. Risk of bias (ROB) was high in 59% of trials, unclear in 33%, and low in 8%. Registered trials were more likely to have low ROB than non-registered trials (16% vs. 5%; p = 0.008). Effect sizes tended to be larger for trials at high vs. low ROB (0.28, 95% CI 0.21,0.35 vs. 0.16, 95% CI 0.07,0.25). Among survey respondents (50% response rate), the most common reason for trial registration was a publication requirement and for non-registration, a lack of familiarity with the process. Conclusions More than half of this random sample of pediatric RCTs published in 2007 was at high ROB and three quarters of trials were not registered. There is an urgent need to improve the design, conduct, and reporting of child health research.
- Published
- 2010
36. Exercise-induced bronchoconstriction and asthma
- Author
-
Donna M, Dryden, Carol H, Spooner, Michael K, Stickland, Ben, Vandermeer, Lisa, Tjosvold, Liza, Bialy, Kai, Wong, and Brian H, Rowe
- Subjects
Asthma, Exercise-Induced ,Male ,Azides ,Serotonin ,Humans ,Adrenergic beta-Agonists ,Randomized Controlled Trials as Topic ,Research Article - Abstract
The objectives are: (1) To assess diagnostic test characteristics of six alternative index tests compared with the selected reference standard-a standardized exercise challenge test (ECT) in patients with suspected exercise-induced bronchoconstriction or asthma (EIB/EIA); (2) to determine the efficacy of a single prophylactic dose of four pharmacologic and one nonpharmacologic interventions vs. placebo to attenuate EIB/EIA in patients with diagnosed EIB/EIA; and (3) to determine if regular daily treatment with short-acting or long-acting beta-agonists (SABA or LABA) causes patients with EIA to develop tachyphylaxis when additional prophylactic doses are used pre-exercise.A systematic and comprehensive literature search was conducted in 14 electronic databases (Diagnosis) and the Cochrane Airways Register (Therapy).Study selection, quality assessment, and data extraction were conducted independently by two reviewers. The primary outcome was the maximum percent fall in the post-exercise forced expiratory volume in 1 second (percent fall FEV1). The diagnostic threshold for a positive ECT was a percent fall FEV1 of 10% or more. Sensitivity (SN) and specificity (SP) were calculated. For therapy, mean differences (MD) in the percent fall FEV1 and 95% confidence intervals (CI) (random effects model) were calculated. A positive MD indicates the intervention works better than the control.For the diagnostic reviews, 5,318 citations yielded 28 relevant studies; for the therapy reviews, 1,634 citations yielded 109 relevant RCTs. Diagnostic test results versus ECT: self-reported history (2 studies) SN=36-8 percent; SP=85-86 percent; sport specific challenges (5 studies) SN=0-100 percent, SP=0-100 percent; eucapnic voluntary hyperpnea (7 studies) SN=25-90 percent, SP=0-71 percent; free running asthma screening test (3 studies) SN=60-67 percent, SP=47-67 percent; mannitol (3 studies) SN=58-96 percent, SP=65-78 percent. All SN and SP calculations indicated substantial heterogeneity that could not be explained by sensitivity or subgroup analyses. Therapy results: SABA offered greater protection than mast cell stabilizers (MCS) (12 studies); MD=6.8 (95 percent CI: 4.5, 9.2) but combining them offered no additional benefit; SABA versus MCS plus SABA (5 studies) MD=1.3 (95 percent CI: -6.3, 8.9). Leukotriene receptor antagonists (LTRA), MCS, ipratropium bromide, and interval warmup routines provided statistically significant attenuation of EIA when compared with placebo; inhaled corticosteroids (ICS) and other warmup routines did not. Single-dose intervention versus placebo results are: LTRA (9 studies) MD=8.9 (95 percent CI: 6.9, 11.0); MCS (nedocromil sodium) (17 studies) MD=15.6 (95 percent CI: 13.2, 18.2); interval warmup versus no warmup (4 studies) MD=10.6 (95 percent CI: 6.5, 14.7); ICS (4 studies) MD=5.0 (95 percent CI: 0.0, 9.9); continuous low intensity warmup versus no warmup (3 studies) MD=12.6 (95 percent CI: -1.5, 26.7); continuous high intensity warmup versus no warmup (2 studies) MD=9.8 (95 percent CI: -6.4, 26.0). After daily LABA (salmeterol) use for 3 to 4 weeks (4 studies), the percent fall FEV1 following an ECT at 2 and 4 weeks was greater than at day 1 in the LABA arm indicating that tachyphylaxis to prophylactic LABA use occurred. Daily SABA use for 1 week (1 study) also indicated development of tachyphylaxis. However, both LABA and SABA continued to have an attenuating effect on EIA.Given the small number of studies comparing EIB/EIA diagnostic tests, the heterogeneity of the study populations, and the varied study methodologies, there is no clear evidence that any of the index tests are a suitable replacement for a standardized ECT to diagnose EIB/EIA in the general population. All bronchodilator agents and most anti-inflammatory agents when used as pretreatment are somewhat effective in attenuating the percent fall FEV1 associated with EIA.
- Published
- 2010
37. Systematic review: nonoperative and operative treatments for rotator cuff tears
- Author
-
Shima S Mousavi, Ben Vandermeer, David M Sheps, Janine R Schouten, Claire LeBlanc, Jennifer C Seida, Lisa Tjosvold, and Lisa Hartling
- Subjects
medicine.medical_specialty ,Evidence-based practice ,Time Factors ,Comparative effectiveness research ,Anti-Inflammatory Agents ,Dexamethasone ,Rotator Cuff Injuries ,Rotator Cuff ,Postoperative Complications ,Internal Medicine ,medicine ,Humans ,Rotator cuff ,Orthopedic Procedures ,Hyaluronic Acid ,Range of Motion, Articular ,Physical Therapy Modalities ,Viscosupplements ,business.industry ,Rotator cuff injury ,General Medicine ,Evidence-based medicine ,medicine.disease ,Clinical trial ,medicine.anatomical_structure ,Systematic review ,Treatment Outcome ,Research Design ,Physical therapy ,Wounds and Injuries ,Steroids ,business ,Health care quality - Abstract
Many approaches exist for managing rotator cuff tears.To compare the benefits and harms of nonoperative and operative interventions on clinically important outcomes in adults with rotator cuff tears.12 electronic databases (1990 to September 2009), gray literature, trial registries, and reference lists were searched.Controlled and uncontrolled studies that assessed nonoperative or operative treatments or postoperative rehabilitation for adults with confirmed rotator cuff tears were included. Operative studies in English-language publications and nonoperative and postoperative rehabilitation studies in English, French, or German were considered. Studies were assessed in duplicate.2 reviewers assessed risk for bias by using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale. One reviewer rated the evidence by using a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Data were extracted by one reviewer and verified by another.137 studies met eligibility criteria. All trials had high risk for bias. Cohort and uncontrolled studies were of moderate quality. Reported functional outcomes did not differ between open versus mini-open repair, mini-open versus arthroscopic repair, arthroscopic repair with versus without acromioplasty, or single-row versus double-row fixation. Earlier return to work was reported for mini-open repair versus open repair and for continuous passive motion with physical therapy versus physical therapy alone. Open repairs showed greater improvement in function than did arthroscopic debridement. Complication rates were low across all interventions.Limited evidence, which was often of low quality, precluded conclusions for most comparisons. Language restrictions may have excluded some relevant studies, and selective outcome reporting may have introduced bias.Evidence on the comparative effectiveness and harms of various operative and nonoperative treatments for rotator cuff tears is limited and inconclusive.Agency for Healthcare Research and Quality.
- Published
- 2010
38. A systematic review of interventions to support siblings of children with chronic illness or disability
- Author
-
Lisa, Hartling, Andrea, Milne, Lisa, Tjosvold, Dawn, Wrightson, Jennifer, Gallivan, and Amanda S, Newton
- Subjects
Male ,Adolescent ,Siblings ,Child Behavior ,Disabled Children ,United States ,Disability Evaluation ,Self-Help Groups ,Child, Preschool ,Chronic Disease ,Humans ,Sibling Relations ,Female ,Interpersonal Relations ,Child ,Needs Assessment ,Randomized Controlled Trials as Topic - Abstract
Chronic illness or disability in children can have a deleterious effect on the psychosocial health of well siblings. This systematic review synthesised evidence from studies evaluating sibling-oriented care aimed at improving behavioural and emotional outcomes in well siblings of children with chronic illness or disability. Twenty electronic databases were searched. Study selection, data extraction and assessment of methodological quality were performed by two independent reviewers. Five controlled and nine uncontrolled studies were included. In higher-quality controlled trials, benefits of sibling-oriented care included reduced anxiety, improved mood and behavioural adjustment; however, these findings were not consistently demonstrated across studies. Study differences made it difficult to determine which sibling care features were most salient. Study findings highlight the potential for enhancing emotional and behavioural outcomes in well siblings. Future evaluations need to clearly identify the intended purpose of the care (what improvements are intended) and which types of siblings are most likely to benefit. This approach may yield more consistent and clinically important results.
- Published
- 2010
39. Treatment of hepatitis C in children: a systematic review
- Author
-
Lisa Tjosvold, Joan L. Robinson, Karen Doucette, Lisa Hartling, and Jia Hu
- Subjects
Infectious Diseases/Gastrointestinal Infections ,medicine.medical_specialty ,Adolescent ,Genotype ,Hepatitis C virus ,Science ,Pediatrics and Child Health ,Neutropenia ,medicine.disease_cause ,Antiviral Agents ,law.invention ,Gastroenterology and Hepatology/Hepatology ,chemistry.chemical_compound ,Randomized controlled trial ,Pegylated interferon ,law ,Internal medicine ,Infectious Diseases/Viral Infections ,Ribavirin ,Medicine ,Humans ,Adverse effect ,Child ,Randomized Controlled Trials as Topic ,Clinical Trials as Topic ,Multidisciplinary ,business.industry ,Infant, Newborn ,Infant ,virus diseases ,Hepatitis C ,medicine.disease ,digestive system diseases ,Systematic review ,chemistry ,Child, Preschool ,Immunology ,Interferons ,business ,medicine.drug ,Research Article - Abstract
BackgroundCurrent guidelines recommend children be treated for hepatitis C virus (HCV) using the same principles applied in adults. There are however few published studies which assess the efficacy and safety of HCV therapy in children.Methodology/principal findingsA systematic review of the literature was completed for studies of any design that evaluated HCV therapy in children. The primary outcome was sustained virologic response (SVR), with sub-group analysis of response rates by genotype. There were 4 randomized controlled trials (RCTs) and 31 non-randomized studies, all involving interferon, pegylated interferon (PEG-IFN), or combinations of these drugs with ribavirin. The SVR rate could not be directly compared as the populations and interventions differed across studies. Genotype was not reported or differed substantially from study to study. The overall SVR rate for PEG-IFN and ribavirin ranged from 30 to 100% which is comparable to the rate in adults. Similar to adults, the SVR rates were significantly higher in children with genotype 2 or 3 compared to genotype 1. Adverse effects were primarily flu-like symptoms and neutropenia. There were insufficient data to assess the applicability of the week 12 stop rule (stopping therapy at week 12 if there is less than a 2 log drop in HCV RNA) or the efficacy of shortening therapy to 24 weeks in children with genotype 2 and 3.Conclusions/significanceCurrent guidelines for the treatment of HCV in children are based on limited data. Further research is needed to define the optimal therapy for HCV in children.
- Published
- 2010
40. A descriptive analysis of child-relevant systematic reviews in the Cochrane Database of Systematic Reviews
- Author
-
Lisa Tjosvold, Lisa Hartling, Denise Thomson, Simon Bow, Jeffrey A. Klassen, Annabritt Chisholm, Terry P. Klassen, and David Moher
- Subjects
Adult ,Databases, Factual ,Subgroup analysis ,computer.software_genre ,03 medical and health sciences ,0302 clinical medicine ,Meta-Analysis as Topic ,030225 pediatrics ,Electronic form ,parasitic diseases ,Research article ,Medicine ,Humans ,030212 general & internal medicine ,Pediatrics, Perinatology, and Child Health ,10. No inequality ,Child ,Analysis of Variance ,Descriptive statistics ,Database ,business.industry ,Age Factors ,lcsh:RJ1-570 ,lcsh:Pediatrics ,Publication bias ,External source ,Jadad scale ,Review Literature as Topic ,Systematic review ,Pediatrics, Perinatology and Child Health ,business ,Topic areas ,computer ,Publication Bias - Abstract
Background Systematic reviews (SRs) are considered an important tool for decision-making. There has been no recent comprehensive identification or description of child-relevant SRs. A description of existing child-relevant SRs would help to identify the extent of available child-relevant evidence available in SRs and gaps in the evidence base where SRs are required. The objective of this study was to describe child-relevant SRs from the Cochrane Database of Systematic Reviews (CDSR, Issue 2, 2009). Methods SRs were assessed for relevance using pre-defined criteria. Data were extracted and entered into an electronic form. Univariate analyses were performed to describe the SRs overall and by topic area. Results The search yielded 1666 SRs; 793 met the inclusion criteria. 38% of SRs were last assessed as up-to-date prior to 2007. Corresponding authors were most often from the UK (41%). Most SRs (59%) examined pharmacological interventions. 53% had at least one external source of funding. SRs included a median of 7 studies (IQR 3, 15) and 679 participants (IQR 179, 2833). Of all studies, 48% included only children, and 27% only adults. 94% of studies were published in peer-reviewed journals. Primary outcomes were specified in 72% of SRs. Allocation concealment and the Jadad scale were used in 97% and 25% of SRs, respectively. Adults and children were analyzed separately in 12% of SRs and as a subgroup analysis in 14%. Publication bias was assessed in only 14% of SRs. A meta-analysis was conducted in 68% of SRs with a median of 5 trials (IQR 3, 9) each. Variations in these characteristics were observed across topic areas. Conclusions We described the methodological characteristics and rigour of child-relevant reviews in the CDSR. Many SRs are not up-to-date according to Cochrane criteria. Our study describes variation in conduct and reporting across SRs and reveals clinicians' ability to access child-specific data.
- Published
- 2010
41. Pediatric Suicide-Related Presentations: A Systematic Review of Mental Health Care in the Emergency Department
- Author
-
Amanda S Newton, Erin Logue, Samina Ali, Lisa Tjosvold, Michele P Hamm, Craig J. Bryan, Ian Manion, Anne E. Rhodes, and Jennifer Bethell
- Subjects
Mental Health Services ,Risk ,Pediatrics ,medicine.medical_specialty ,Referral ,Adolescent ,Psychological intervention ,Poison control ,Suicide, Attempted ,Cochrane Library ,Article ,law.invention ,Randomized controlled trial ,law ,Intensive care ,Confidence Intervals ,Odds Ratio ,Medicine ,Humans ,Child ,Referral and Consultation ,business.industry ,Emergency department ,Patient Discharge ,Relative risk ,Emergency medicine ,Emergency Medicine ,business ,Emergency Service, Hospital - Abstract
Study objective We evaluate the effectiveness of interventions for pediatric patients with suicide-related emergency department (ED) visits. Methods We searched of MEDLINE, EMBASE, the Cochrane Library, other electronic databases, references, and key journals/conference proceedings. We included experimental or quasiexperimental studies that evaluated psychosocial interventions for pediatric suicide-related ED visits. Inclusion screening, study selection, and methodological quality were assessed by 2 independent reviewers. One reviewer extracted the data and a second checked for completeness and accuracy. Consensus was reached by conference; disagreements were adjudicated by a third reviewer. We calculated odds ratios, relative risks (RRs), or mean differences for each study's primary outcome, with 95% confidence intervals (CIs). Meta-analysis was deferred because of clinical heterogeneity in intervention, patient population, and outcome. Results We included 7 randomized controlled trials and 3 quasiexperimental studies, grouping and reviewing them according to intervention delivery: ED-based delivery (n=1), postdischarge delivery (n=6), and ED transition interventions (n=3). An ED-based discharge planning intervention increased the number of attended post-ED treatment sessions (mean difference=2.6 sessions; 95% CI 0.05 to 5.15 sessions). Of the 6 studies of postdischarge delivery interventions, 1 found increased adherence with service referral in patients who received community nurse home visits compared with simple placement referral at discharge (RR=1.28; 95% CI 1.06 to 1.56). The 3 ED transition intervention studies reported (1) reduced risk of subsequent suicide after brief ED intervention and postdischarge contact (RR=0.10; 95% CI 0.03 to 0.41); (2) reduced suicide-related hospitalizations when ED visits were followed up with interim, psychiatric care (RR=0.41; 95% CI 0.28 to 0.60); and (3) increased likelihood of treatment completion when psychiatric evaluation in the ED was followed by attendance of outpatient sessions with a parent (odds ratio=2.78; 95% CI 1.20 to 6.67). Conclusion Transition interventions appear most promising for reducing suicide-related outcomes and improving post-ED treatment adherence. Use of similar interventions and outcome measures in future studies would enhance the ability to derive strong recommendations from the clinical evidence in this area.
- Published
- 2010
42. Problem-based learning in pre-clinical medical education: 22 years of outcome research
- Author
-
Lisa Tjosvold, Lisa Hartling, Carol Spooner, and Anna Oswald
- Subjects
Program evaluation ,Medical education ,education ,MEDLINE ,General Medicine ,PsycINFO ,Problem-Based Learning ,Knowledge acquisition ,Education ,Critical appraisal ,Problem-based learning ,Internship ,Humans ,Psychology ,Inclusion (education) ,Education, Medical, Undergraduate ,Program Evaluation - Abstract
Purpose: To conduct a systematic review of problem-based learning (PBL) in undergraduate, pre-clinical medical education. Methods: A research librarian developed comprehensive search strategies for MEDLINE, PSYCINFO, and ERIC (1985–2007). Two reviewers independently screened search results and applied inclusion criteria. Studies were included if they had a comparison group and reported primary data for evaluative outcomes. One reviewer extracted data and a second reviewer checked data for accuracy. Two reviewers independently assessed methodological quality. Quantitative synthesis was not performed due to heterogeneity. A qualitative review with detailed evidence tables is provided. Results: Thirty unique studies were included. Knowledge acquisition measured by exam scores was the most frequent outcome reported; 12 of 15 studies found no significant differences. Individual studies demonstrated either improved clerkship (N ¼ 3) or residency (N ¼ 1) performance, or benefits on some clinical competencies during internships for PBL (N ¼ 1). Three of four studies found some benefits for PBL when evaluating diagnostic accuracy. Three studies found few differences of clinical (or practical) importance on the impact of PBL on practicing physicians. Conclusions: Twenty-two years of research shows that PBL does not impact knowledge acquisition; evidence for other outcomes does not provide unequivocal support for enhanced learning. Work is needed to determine the most appropriate outcome measures to capture and quantify the effects of PBL. General conclusions are limited by methodological weaknesses and heterogeneity across studies. The critical appraisal of previous studies, conducted as part of this review, provides direction for future research in this area.
- Published
- 2010
43. Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006
- Author
-
Ben Vandermeer, Eyal Cohen, Lisa Hartling, Denise Thomson, Terry P. Klassen, and Lisa Tjosvold
- Subjects
Non-Clinical Medicine/Research Methods ,Male ,Pediatrics ,medicine.medical_specialty ,Blinding ,Adolescent ,MEDLINE ,Pediatrics and Child Health ,lcsh:Medicine ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,030225 pediatrics ,Medicine ,Humans ,030212 general & internal medicine ,Child ,lcsh:Science ,Randomized Controlled Trials as Topic ,Multidisciplinary ,Descriptive statistics ,business.industry ,Publications ,lcsh:R ,Jadad scale ,3. Good health ,Clinical trial ,Systematic review ,Sample size determination ,Child, Preschool ,Female ,lcsh:Q ,Controlled Clinical Trials as Topic ,business ,Evidence-Based Healthcare/Statistical Methodologies and Health Informatics ,Research Article - Abstract
Background The objective of this study was to describe randomized controlled trials (RCTs) and controlled clinical trials (CCTs) in child health published between 1948 and 2006, in terms of quantity, methodological quality, and publication and trial characteristics. We used the Trials Register of the Cochrane Child Health Field for overall trends and a sample from this to explore trial characteristics in more detail. Methodology/Principal Findings We extracted descriptive data on a random sample of 578 trials. Ninety-six percent of the trials were published in English; the percentage of child-only trials was 90.5%. The most frequent diagnostic categories were infectious diseases (13.2%), behavioural and psychiatric disorders (11.6%), neonatal critical care (11.4%), respiratory disorders (8.9%), non-critical neonatology (7.9%), and anaesthesia (6.5%). There were significantly fewer child-only studies (i.e., more mixed child and adult studies) over time (P = 0.0460). The proportion of RCTs to CCTs increased significantly over time (P
- Published
- 2010
44. Nutritional support for critically ill children
- Author
-
Bodil Larsen, Ben Vandermeer, Laurance Lequier, Natalie Anton, Ari R. Joffe, Lisa Tjosvold, and Lisa Hartling
- Subjects
Medicine General & Introductory Medical Sciences ,medicine.medical_specialty ,Time Factors ,Critical Illness ,Clinical nutrition ,Intensive Care Units, Pediatric ,Enteral administration ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Enteral Nutrition ,Randomized controlled trial ,law ,Intensive care ,Medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Intensive care medicine ,Child ,Randomized Controlled Trials as Topic ,business.industry ,Infant ,030208 emergency & critical care medicine ,Publication bias ,Intensive care unit ,Clinical trial ,Parenteral nutrition ,business ,Burns - Abstract
Background Nutritional support in the critically ill child has not been well investigated and is a controversial topic within paediatric intensive care. There are no clear guidelines as to the best form or timing of nutrition in critically ill infants and children. This is an update of a review that was originally published in 2009. . Objectives The objective of this review was to assess the impact of enteral and parenteral nutrition given in the first week of illness on clinically important outcomes in critically ill children. There were two primary hypotheses: 1. the mortality rate of critically ill children fed enterally or parenterally is different to that of children who are given no nutrition; 2. the mortality rate of critically ill children fed enterally is different to that of children fed parenterally. We planned to conduct subgroup analyses, pending available data, to examine whether the treatment effect was altered by: a. age (infants less than one year versus children greater than or equal to one year old); b. type of patient (medical, where purpose of admission to intensive care unit (ICU) is for medical illness (without surgical intervention immediately prior to admission), versus surgical, where purpose of admission to ICU is for postoperative care or care after trauma). We also proposed the following secondary hypotheses (a priori), pending other clinical trials becoming available, to examine nutrition more distinctly: 3. the mortality rate is different in children who are given enteral nutrition alone versus enteral and parenteral combined; 4. the mortality rate is different in children who are given both enteral feeds and parenteral nutrition versus no nutrition. Search methods In this updated review we searched: the Cochrane Central Register of Controlled Trials (CENTRAL 2016, Issue 2); Ovid MEDLINE (1966 to February 2016); Ovid EMBASE (1988 to February 2016); OVID Evidence-Based Medicine Reviews; ISI Web of Science - Science Citation Index Expanded (1965 to February 2016); WebSPIRS Biological Abstracts (1969 to February 2016); and WebSPIRS CAB Abstracts (1972 to February 2016). We also searched trial registries, reviewed reference lists of all potentially relevant studies, handsearched relevant conference proceedings, and contacted experts in the area and manufacturers of enteral and parenteral nutrition products. We did not limit the search by language or publication status. Selection criteria We included studies if they were randomized controlled trials; involved paediatric patients, aged one day to 18 years of age, who were cared for in a paediatric intensive care unit setting (PICU) and had received nutrition within the first seven days of admission; and reported data for at least one of the pre-specified outcomes (30-day or PICU mortality; length of stay in PICU or hospital; number of ventilator days; and morbid complications, such as nosocomial infections). We excluded studies if they only reported nutritional outcomes, quality of life assessments, or economic implications. Furthermore, we did not address other areas of paediatric nutrition, such as immunonutrition and different routes of delivering enteral nutrition, in this review. Data collection and analysis Two authors independently screened the searches, applied the inclusion criteria, and performed 'Risk of bias' assessments. We resolved discrepancies through discussion and consensus. One author extracted data and a second checked data for accuracy and completeness. We graded the evidence based on the following domains: study limitations, consistency of effect, imprecision, indirectness, and publication bias. Main results We identified only one trial as relevant. Seventy-seven children in intensive care with burns involving more than 25% of the total body surface area were randomized to either enteral nutrition within 24 hours or after at least 48 hours. No statistically significant differences were observed for mortality, sepsis, ventilator days, length of stay, unexpected adverse events, resting energy expenditure, nitrogen balance, or albumin levels. We assessed the trial as having unclear risk of bias. We consider the quality of the evidence to be very low due to there being only one small trial. In the most recent search update we identified a protocol for a relevant randomized controlled trial examining the impact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients; no results have been published. Authors' conclusions There was only one randomized trial relevant to the review question. Research is urgently needed to identify best practices regarding the timing and forms of nutrition for critically ill infants and children.
- Published
- 2009
45. CORRIGENDA
- Author
-
Jeffrey Johnson and Lisa Tjosvold
- Subjects
Blood Glucose ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,Vitamins ,Corrections ,Biochemistry ,Prediabetic State ,Endocrinology ,Diabetes Mellitus, Type 2 ,Dietary Supplements ,Homeostasis ,Humans ,Cholecalciferol ,Randomized Controlled Trials as Topic - Abstract
Observational studies report consistent associations between low vitamin D concentration and increased glycemia and risk of type 2 diabetes, but results of randomized controlled trials (RCTs) are mixed.The objective of the study was to systematically review RCTs that report on the effects of vitamin D supplementation on glucose homeostasis or diabetes prevention.Sources of data for the study were MEDLINE, EMBASE, SCOPUS, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Health Technology Assessment, and Science Citation Index from inception to June 2013.Study selection was trials that compared vitamin D3 supplementation with placebo or a non-vitamin D supplement in adults with normal glucose tolerance, prediabetes, or type 2 diabetes.Two reviewers collected data and assessed trial quality using the Cochrane Risk of Bias tool. Random-effects models were used to estimate mean differences (MDs) and odds ratios. The main outcomes of interest were homeostasis model assessment of insulin resistance, homeostasis model assessment of β-cell function, hemoglobin A1c levels, fasting blood glucose, incident diabetes, and adverse events.Thirty-five trials (43 407 patients) with variable risk of bias were included. Vitamin D had no significant effects on insulin resistance [homeostasis model assessment of insulin resistance: MD -0.04; 95% confidence interval (CI) -0.30 to 0.22, I-squared statistic (I(2)) = 45%], insulin secretion (homeostasis model of β-cell function: MD 1.64; 95% CI -25.94 to 29.22, I(2) = 40%), or hemoglobin A1c (MD -0.05%; 95% CI -0.12 to 0.03, I(2) = 55%) compared with controls. Four RCTs reported on the progression to new diabetes and found no effect of vitamin D (odds ratio 1.02; 95% CI 0.94 to 1.10, I(2) = 0%). Adverse events were rare, and there was no evidence of publication bias.Evidence from available trials shows no effect of vitamin D3 supplementation on glucose homeostasis or diabetes prevention. Definitive conclusions may be limited in the context of the moderate degree of heterogeneity, variable risk of bias, and short-term follow-up duration of the available evidence to date.
- Published
- 2015
46. Does melatonin improve sleep?: Efficacy of melatonin
- Author
-
Lisa Hartling, Glen B. Baker, Ben Vandermeer, Nina Buscemi, Lisa Tjosvold, Sunita Vohra, Nicola Hooton, Rena Pandya, and Terry P. Klassen
- Subjects
Adult ,Male ,Sleep Wake Disorders ,medicine.medical_specialty ,Adolescent ,Treatment outcome ,Neurological disorder ,Bioinformatics ,Melatonin ,Dark therapy ,Internal medicine ,Medicine ,Humans ,Circadian rhythm ,Letters ,Psychiatry ,Child ,General Environmental Science ,Sleep restriction ,Aged ,Randomized Controlled Trials as Topic ,Sleep disorder ,business.industry ,Research ,General Engineering ,Infant, Newborn ,Infant ,General Medicine ,Middle Aged ,medicine.disease ,Sleep in non-human animals ,Jadad scale ,Endocrinology ,Treatment Outcome ,Meta-analysis ,Child, Preschool ,Physical therapy ,General Earth and Planetary Sciences ,Jet Lag Syndrome ,Female ,Sleep onset latency ,business ,medicine.drug - Abstract
Objective To conduct a systematic review of the efficacy and safety of exogenous melatonin in managing secondary sleep disorders and sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder. Data sources 13 electronic databases and reference lists of relevant reviews and included studies; Associated Professional Sleep Society abstracts (1999 to 2003). Study selection The efficacy review included randomised controlled trials; the safety review included randomised and non-randomised controlled trials. Quality assessment Randomised controlled trials were assessed by using the Jadad Scale and criteria by Schulz et al, and non-randomised controlled trials by the Downs and Black checklist. Data extraction and synthesis One reviewer extracted data and another reviewer verified the data extracted. The inverse variance method was used to weight studies and the random effects model was used to analyse data. Main results Six randomised controlled trials with 97 participants showed no evidence that melatonin had an effect on sleep onset latency in people with secondary sleep disorders (weighted mean difference −13.2 (95% confidence interval −27.3 to 0.9) min). Nine randomised controlled trials with 427 participants showed no evidence that melatonin had an effect on sleep onset latency in people who had sleep disorders accompanying sleep restriction (−1.0 (−2.3 to 0.3) min). 17 randomised controlled trials with 651 participants showed no evidence of adverse effects of melatonin with short term use (three months or less). Conclusions There is no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder. There is evidence that melatonin is safe with short term use.
- Published
- 2006
47. The Efficacy and Safety of Exogenous Melatonin for Primary Sleep Disorders: A Meta-Analysis
- Author
-
Lisa Tjosvold, Nina Buscemi, Ben Vandermeer, Rena Pandya, Lisa Hartling, Sunita Vohra, Glen B. Baker, Nicola Hooton, and Terry P. Klassen
- Subjects
Sleep Wake Disorders ,endocrine system ,medicine.medical_specialty ,Clinical Review ,Exogenous melatonin ,Neurological disorder ,Bioinformatics ,Primary sleep disorders ,Melatonin ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Hypnotics and Sedatives ,Circadian rhythm ,Sleep disorder ,business.industry ,medicine.disease ,Sleep in non-human animals ,Endocrinology ,Treatment Outcome ,Meta-analysis ,business ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug - Abstract
Exogenous melatonin has been increasingly used in the management of sleep disorders.To conduct a systematic review of the efficacy and safety of exogenous melatonin in the management of primary sleep disorders.A number of electronic databases were searched. We reviewed the bibliographies of included studies and relevant reviews and conducted hand-searching.Randomized controlled trials (RCTs) were eligible for the efficacy review, and controlled trials were eligible for the safety review.One reviewer extracted data, while the other verified data extracted. The Random Effects Model was used to analyze data.Melatonin decreased sleep onset latency (weighted mean difference [WMD]: -11.7 minutes; 95% confidence interval [CI]: -18.2, -5.2)); it was decreased to a greater extent in people with delayed sleep phase syndrome (WMD: -38.8 minutes; 95% CI: -50.3, -27.3; n=2) compared with people with insomnia (WMD: -7.2 minutes; 95% CI: -12.0, -2.4; n=12). The former result appears to be clinically important. There was no evidence of adverse effects of melatonin.There is evidence to suggest that melatonin is not effective in treating most primary sleep disorders with short-term use (4 weeks or less); however, additional large-scale RCTs are needed before firm conclusions can be drawn. There is some evidence to suggest that melatonin is effective in treating delayed sleep phase syndrome with short-term use. There is evidence to suggest that melatonin is safe with short-term use (3 months or less).
- Published
- 2005
48. Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review
- Author
-
Ahmed M. Abou-Setta, Lauren A. Beaupre, Saifee Rashiq, Donna M. Dryden, Michele P. Hamm, Cheryl A. Sadowski, Matthew R.G. Menon, Sumit R. Majumdar, Donna M. Wilson, Mohammad Karkhaneh, Shima S. Mousavi, Kai Wong, Lisa Tjosvold, and C. Allyson Jones
- Subjects
Comparative Effectiveness Research ,medicine.medical_specialty ,medicine.medical_treatment ,Comparative effectiveness research ,Pain ,Acupressure ,Relaxation Therapy ,Anesthesia, Spinal ,Traction ,Internal Medicine ,medicine ,Humans ,Pain Management ,Analgesics ,Hip fracture ,Rehabilitation ,Hip Fractures ,business.industry ,Chronic pain ,Delirium ,Nerve Block ,General Medicine ,medicine.disease ,Combined Modality Therapy ,Inclusion and exclusion criteria ,Transcutaneous Electric Nerve Stimulation ,Physical therapy ,medicine.symptom ,business ,Cohort study - Abstract
Background: Pain management is integral to the management of hip fracture. Purpose: To review the benefits and harms of pharmacologic and nonpharmacologic interventions for managing pain after hip fracture. Data Sources: 25 electronic databases (January 1990 to December 2010), gray literature, trial registries, and reference lists, with no language restrictions. Study Selection: Multiple reviewers independently, and in duplicate, screened 9357 citations to identify randomized, controlled trials (RCTs); nonrandomized, controlled trials (non-RCTs); and cohort studies of pain management techniques in older adults after acute hip fracture. Data Extraction: Independent, duplicate data extraction and quality assessment were conducted, with discrepancies resolved by consensus or a third reviewer. Data extracted included study characteristics, inclusion and exclusion criteria, participant characteristics, interventions, and outcomes. Data Synthesis: 83 unique studies (64 RCTs, 5 non-RCTs, and 14 cohort studies) that addressed the following interventions were included: nerve blockade (n = 32), spinal anesthesia (n = 30), systemic analgesia (n = 3), traction (n = 11), multimodal pain management (n = 2), neurostimulation (n = 2), rehabilitation (n = 1), and complementary and alternative medicine (n = 2). Overall, moderate evidence suggests that nerve blockades are effective for relieving acute pain and reducing delirium. Low-level evidence suggests that preoperative traction does not reduce acute pain. Evidence was insufficient about the benefits and harms of most interventions, including spinal anesthesia, systemic analgesia, multimodal pain management, acupressure, relaxation therapy, transcutaneous electrical neurostimulation, and physical therapy regimens, in managing acute pain. Limitations: No studies evaluated outcomes of chronic pain or exclusively examined participants from nursing homes or with cognitive impairment. Systemic analgesics (narcotics, nonsteroidal anti-inflammatory drugs) were understudied during the search period. Conclusion: Nerve blockade seems effective in reducing acute pain after hip fracture. Sparse data preclude firm conclusions about the relative benefits or harms of many other pain management interventions for patients with hip fracture. Primary Funding Source: Agency for Healthcare Research and Quality.
- Published
- 2011
49. Music for pain and anxiety in children undergoing medical procedures: A systematic review of randomized controlled trials
- Author
-
Lisa Tjosvold, Lisa Hartling, Terry P. Klassen, Yuanyuan Liang, and Jeffrey A. Klassen
- Subjects
medicine.medical_specialty ,Music therapy ,MEDLINE ,Pain ,Anxiety ,Article ,law.invention ,Randomized controlled trial ,law ,Intervention (counseling) ,medicine ,Humans ,Active listening ,Child ,Music Therapy ,Diagnostic Techniques and Procedures ,Randomized Controlled Trials as Topic ,business.industry ,General Medicine ,Publication bias ,humanities ,Confidence interval ,Anesthesiology and Pain Medicine ,Strictly standardized mean difference ,Meta-analysis ,Surgical Procedures, Operative ,Pediatrics, Perinatology and Child Health ,Emergency Medicine ,Physical therapy ,medicine.symptom ,business ,human activities ,Clinical psychology - Abstract
Objective The aim of this study was to conduct a systematic review of the efficacy of music therapy (MT) on pain and anxiety in children undergoing clinical procedures. Methods We searched 16 electronic databases of published and unpublished studies, subject bibliographies, reference lists of relevant articles, and trials registries. Two reviewers independently screened 4559 citations and reviewed the full manuscript of 393 studies. Nineteen studies met the inclusion criteria: randomized controlled trial, children aged 1 month to 18 years were examined, music was used as an intervention, and the study measured pain or anxiety. Music therapy was considered active if a music therapist was involved and music was used as a medium for interactive communication. Passive music therapy was defined as listening to music without the involvement of a music therapist. Results The 19 included trials involved 1513 subjects. The methodological quality of the studies was generally poor. Overall, MT showed a significant reduction in pain and anxiety (standardized mean difference [SMD] −0.35; 95% confidence interval [CI], −0.55 to −0.14; 9 studies; N=704; I 2 = 42%). When analyzed by outcome, MT significantly reduced anxiety (SMD −0.39; 95% CI, −0.76 to −0.03; 5 studies; n=284; I 2 = 52.4%) and pain (SMD −0.39; 95% CI, −0.66 to −0.11; 5 studies; N=465; I 2 = 49.7%). There was no evidence of publication bias. Conclusions Music is effective in reducing anxiety and pain in children undergoing medical and dental procedures. Music can be considered an adjunctive therapy in clinical situations that produce pain or anxiety.
- Published
- 2008
50. Glucocorticoids for acute viral bronchiolitis in infants and young children
- Author
-
Fernandes, R. M., Bialy, L. M., Vandermeer, B., Lisa Tjosvold, Plint, A. C., Patel, H., Johnson, D. W., Klassen, T. P., and Hartling, L.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.